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ABSTRACT 
 
 
Fluorescence-based biomarker detection in serum, saliva, urine, or breath condensate 
samples holds great promise for disease diagnostics and therapy monitoring because of its non-
invasive nature. The microarray format, for its high-throughput and low analyte consumption 
characteristics, is particularly well suited for such applications since testing with acceptable 
levels of clinical sensitivity and specificity requires the use of a panel of atleast four to ten 
biomarkers in part due to inherent genetic diversity. While there exist reports on novel optical 
and electrochemical approaches capable of detection biomarkers at concentrations in the 
subpicomolar range, currently no platforms for the multiplexed cancer biomarker detection are in 
widespread use in point-of-care (POC) settings. This work presents the application of photonic 
crystal (PC) surfaces a platform for fluorescence enhancement utilized to improve detection 
sensitivity and as a platform for label free (LF) detection utilized for microspot quality analysis 
and anticipated to complement the fluorescence modality.  
First, a demonstration of the PC enabled LF imaging is applied to the quality analysis of 
printed spots in a DNA microarray. The first generation of polymer-based PCs is utilized 
alongside a high resolution label-free imaging detection instrument. By automating the process 
of identify missed spots and the assignment of a spot quality score for remaining features based 
on the acquired quantitative LF images, the variability in microarray data was captured  reduced 
and accuracy improved.  
Next, the fluorescent enhancement properties of a novel second generation of quartz-
based PCs as a function of resonant angle were characterized in the context of DNA microarrays 
using a commercial microarray scanner. For the first time, the impact of multi-wavelength PC 
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fluorescence enhancement was characterized in a two-color DNA microarray using Cyanine-5 
(Cy5) and Cyanine-3 (Cy3). Observed enhancements in spot signal intensity and spot signal-to-
noise ratio resulted in a 2x increase in the number of genes that were detected on the PC relative 
to standard glass microscope slides for each color. Meaningful enhancements in signal intensities 
and more importantly signal-to-noise ratios at shorter excitation wavelengths (as is the case for 
Cy3) were made possible only due to the negligible substrate fluorescence of the quartz-based 
PCs.  
Finally, a third generation of PCs based in silicon was successfully pursued to address the 
need to combine the negligible substrate fluorescence characteristics of the quartz-based PCs 
with an inexpensive and high-throughput fabrication process. The fluorescence enhancement 
afforded by silicon PCs combined with a compact detection instrument for optimal coupling 
incident light to PC resonant modes was characterized in the context of two types of biomarker 
assays. Using only 10 µL of analyte solutions, protein and miRNA biomarkers implicated in 
cancer were detected at concentrations as low as 0.1pM and 0.6pM, respectively. This work lays 
the foundation for the development of a PC enhanced fluorescence (PCEF) based detection 
platform for POC diagnostics. 
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CHAPTER 1: INTRODUCTION 
 
 The detection of biomarkers whose change in concentration correlates with the onset and 
progression of a disease or the disease response to therapy is the subject of increased scientific 
and clinical interest. If successfully validated, such biomarkers can play a key, non-invasively 
detectable role in early detection, the more accurate differentiation of disease types, and the 
assessment of response to a personalized treatment regimen. The ability to measure panels of 
such validated biomarkers that are specific to a particular disease rapidly during physicians’ 
surgery and in clinics can revolutionize the field of diagnostic detection and monitoring. The 
ambitious goal pursed by several researches is a detection platform that can boast of the 
following characteristics – reliability, low cost, high degree of automation, low user technical 
expertise requisites, and on-spot diagnoses in clinical settings. Most existing commercial 
solutions for biomarker detection display high reliability in controlled, laboratory settings but 
have limitations for POC applications. There remains an unanswered need for a high detection 
sensitivity detection platform for biomarker panels that can be ported to non-laboratory settings 
and has acceptable levels of clinical sensitivity and specificity.   
 
1.1 Employing enhanced fluorescence for improving the sensitivity of 
microarrays 
Fluorescence-based detection remains a critical tool in biological research, where by 
labeling biomolecules with a fluorophore, one is able to determine the spatial distribution of 
molecules (cellular imaging), determine the abundance of particular analytes (DNA and protein 
2 
 
microarrays), sequence DNA, track molecular interactions (Fluorescence Resonant Energy 
Transfer), and interrogate several other interesting biological events. Here, the ability to detect 
weak fluorescent signals above the background fluorescence is crucial for the detection of 
labeled biomolecules that are present at very low concentrations.  
Since their first introduction in the scientific literature in 1982, microarrays have 
revolutionized the study of gene expression. Microarray analysis has since then extended to the 
high throughput study of a host of other biological analytes such as proteins, peptides, tissue, 
cells, antibodies, and chemical compounds. The DNA microarray gained prominence as a 
fluorescence-based tool for the high throughput quantification of gene expression, allowing a 
large number of candidate genes to be examined for differential expression simultaneously 
without extensive prior knowledge of gene functions. Eukaryotic gene expression is typically 
characterized by a large number of genes expressed at very low levels and a decreasing number 
of genes expressed at high levels 1-2.  Usually the fluorescence intensity of only high expression 
genes - a small fraction of all genes in a cell population - can be detected above the noise in the 
experiment. But it is the profiling of low expression genes, many of which have important 
housekeeping functions, which is of keen biological interest. DNA microarrays have also been 
used in genotyping for point mutations, single nucleotide polymorphisms (SNPs), and short 
tandem repeats (STRs) 3. With reductions in the cost for sequencing DNA in recent years, the 
microarray format had lost favor to RNA-seq in the area of transcriptome profiling 4. However, 
with the increased interest in microRNA (miRNA) as a potential disease biomarker, the 
popularity of DNA microarrays for miRNA detection as a low-cost, high throughput diagnostic 
platform has risen 5. 
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 Antibody-based protein microarrays, have also in the recent years gained prominence as a 
valuable tool for studying cellular protein production with potential applications as a clinical tool 
in disease diagnosis and drug discovery 6-9. Protein microarrays are a favorable platform for the 
detection of circulating biomarkers because they combine multiplexed detection, minimal 
reagent usage, and high sensitivity. By running calibration standards alongside patient samples, 
protein microarrays provide quantitative measurements of analyte concentration. Furthermore, 
protocols have been developed that demonstrate multiplexed detection of biomarkers in serum 
through fluorophore-tagged secondary antibodies 10-11. In many clinically relevant applications, 
such as for detection of biomarker proteins that are expressed by cancer cells at a tumor site and 
subsequently diluted by the total blood volume of a person, a target protein may only be present 
at concentrations in the 1-100 pg/mL range 12-15. There is substantial interest in extending the 
limits of detection (LOD) and generally increasing the SNR in order to diagnose disease at the 
earliest possible stage and to quantify biomarker levels at concentrations that were below 
previous limits of detection. Fluorescent-based detection of chemically tagged analytes has been 
demonstrated as a robust, highly specific, and easily multiplexed method for achieving high 
sensitivity 16-21.  
Fluorescence is most simply defined as the molecular absorption of photons at a 
wavelength and its re-emission at another, longer wavelength (also referred to as a stokes shift). 
The fluorescence process can be broken down into three phases – (i) excitation, where the 
fluorophore absorbs light of an appropriate wavelength, (ii) excited state, where the fluorophore 
undergoes vibrational and conformational changes, and (iii) emission, where longer wavelength 
photons are emitted (see Figure 1.1 (a)). This process is cyclical which means that a fluorophore 
can be repeatedly excited. The emission process is in the company of three other competing 
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processes that can also occur. First, energy can be transferred to a nearby fluorophore. Second, 
there can be a non-radiative internal conversion to the ground state. Finally, there can be crossing 
to a triplet state where energy is then dissipated via radiative (like phosphorescence) or non-
radiative pathways (see Figure 1.1 (b)).  
A fluorophore is defined by the following four key characteristics. First, each dye has a 
maximum excitation and emission wavelength that corresponds to the peak in the excitation and 
emission spectra (see Figure 1.2). Second, the molar extinction coefficient of a dye which is a 
measure of its light absorbing capacity; a higher extinction coefficient indicates a more efficient 
absorber. The concentration of a fluorophore solution is also determined by measuring the 
solution’s absorbance and using the dye’s molar extinction coefficient along with the Beer-
Lambert law that relates the three parameters. Third, the dye’s quantum yield which is the ratio 
between the fluorescence photons emitted and the number of photons absorbed is a measure of 
the efficiency of incident energy transfer. The brightness of a fluorophore is proportional to the 
product of the extinction coefficient and quantum yield. By extension, the brightness of a 
fluorescently labeled molecule is proportional to the brightness of the dye and the number of 
dyes per molecule. Fourth, the fluorescence lifetime (typically in picoseconds) of the dye which 
is the mean time spent in the excited state before returning to its ground state. It refers to the time 
taken for a population of excited fluorophores to decay to ~ 37% (1/e) of the original number. It 
should be noted that the excited state lifetimes can change with changes in the dye’s 
environment. These characteristics drive other properties, including photobleaching which is the 
loss of fluorescence upon continuous light excitation. The ideal dye for microarray applications 
will have a high extinction coefficient, a high quantum yield, a long fluorescence lifetime, and is 
less prone to photobleaching. While some proteins and small molecules in cells (for e.g. 
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tryptophan, endogenous chlorophyll, phycoerythrine) are found in nature to possess intrinsic 
fluorescence, short lifetimes and low quantum yields plague such fluorophores. Synthetic 
organic dyes are the other class of extrinsic fluorophores that typically contain several combined 
aromatic groups, or plane or cyclic molecules with several pi bonds. These molecules fluoresce 
due to delocalized electrons that can jump an energy band and stabilize the absorbed energy. The 
Alexa Fluor family of fluorescent dyes by Molecule Probes and the Cyanine family of dyes by 
GE Healthcare are popular in the field of fluorescence microscopy. 
Approaches aimed at augmenting the performance of fluorescence molecules by 
engineering various metal or dielectric surfaces, and nano-structured configurations have been 
reported. In engineering such surfaces to improve the performance of a fluorophore, efforts are 
aimed at enhancing the excitation of these molecules and/or providing directionality to the 
emitted light for improved collection. In the case of metal enhanced fluorescence, the metal 
surface’s ability to concentrate the local excitation intensity, leading to an amplification of the 
incident field, is one mechanism through which fluorescent intensity is increased. Arrays of 
metallic nano-islands, patterned using microfabrication techniques, have also shown to enhance 
fluorescence excitation through the creation of local hot spots of high electric field intensity 
(surface plasmons) that overlaps the fluorphore excitation wavelength 22-25. However, there are 
two important drawbacks to metal-enabled fluorescence enhancement. First, in a regime close to 
the surface (~10nm), fluorescence quenching through energy transfer from the fluorophore to the 
conductive metal layer, causes a reduction in the fluorescence output 26. Second, surface 
plasmons support low quality factor resonant modes due to the conductive nature of metals, 
resulting in an inability to store large amounts of incident electric field intensity for fluorescence 
enhancement.  
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Dielectric-based surfaces have also been used in an attempt to improve the sensitivity of 
fluorescence detection. In total internal reflection fluorescence (TIRF) microscopy, light is 
coupled into a planar waveguide where it evanescently excites fluorophores on the device 
surface.  By exciting only the fluorophores on the surface using evanescent coupling, 
background fluorescence and scattering or absorption from other components in the sample can 
be minimized.  However, unlike an optical resonator, this structure does not store energy at the 
excitation wavelength and the observed modest fluorescence improvements come only from 
restricting the thickness of the excitation region 27.  
Corrugated waveguide structures constructed from dielectric materials are another class 
of optical resonators that can evanescently enhance the fluorescence of dyes immobilized on the 
surface of the device 28-29. The 1-D surface PC employed in this work is one such example and 
comprises a periodic structure as the bottom layer that is formed on a low refractive index 
material (for eg. polymer or quartz) and a high refractive index layer of TiO2 as the top layer. 
The created periodic modulation in refractive index along the device surface gives rise to optical 
resonances when the device is illuminated at a particular wavelength and incident angle 
combination. At this resonant condition, the optical energy is tightly confined to the surface of 
the photonic crystal and yields enhanced fields that are much higher in intensity that the incident 
field due to a process of constructive interference. Spectrally, the manifestation of this resonant 
condition is in the form of a narrow peak with ~100% reflection efficiency at the resonant 
wavelength and incident angle combination 30-31. While the device primarily provides 
fluorescence gains by the enhancing the excitation of the molecule through these enhanced 
fields, a second mechanism focused on the more efficient extraction of emitted photons also 
provides fluorescence enhancement. When a fluorescent molecule is excited, the emitted photons 
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are randomly oriented in free space and only a portion of this light that falls within the collection 
angle of the detection optics is captured. By designing PC resonances that overlap the 
fluorescence emission spectrum, emitted photons can be coupled to these modes, making them 
strongly spatially biased to a narrow set of angles directed towards the detector. PCs can be 
designed to incorporate each enhancement mechanism separately or both simultaneously for 
single or multi-wavelength fluorescence enhancement 32-35.  
 
1.2 Label-free imaging for the quality analysis of printed microspots 
Despite the proven usefulness of microarrays in life science research and as a medical 
diagnostic, there exist some limitations in the arena of reproducibility 36.  This has been 
recognized by the FDA as well as the research community and has led to responses such as the 
introduction of the Microarray Quality Control (MAQC) project for helping improve the 
microarray as well as next-generation sequencing technologies and foster their proper 
applications in discovery, development and review of FDA regulated products. With the complex 
and sometimes non-standardized set of molecular biology protocols, instrumentation, and data 
post-processing algorithms used in microarray analysis, it comes as no surprise that reliable data 
is difficult to attain. One major source of variability with microarrays is spot quality.  Substrate 
quality, surface chemistry, spotting buffer, the spotting tool used and condition, environmental 
humidity, target density, volume of spotting buffer in source wells, and binding/crosslinking and 
wash conditions all affect the morphology and density of each spot on the microarray 37.  Many 
of these variables can change on a spot-to-spot and sample-to-sample basis and so global 
corrections are often insufficient.  The magnitude of variability across different commercial slide 
preparations, instrumentation, and even the labs performing the techniques is in the range of 5-
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20% 38-39.  To address this problem, the use of intra- and interarray duplicates has be adopted to 
improve statistics and discard outliers, but such a method cannot provide any normalization 
based on spot quality aside from determining “dropouts,” or missing spots. Furthermore for 
small-area, miniature arrays where assay real-estate is greatly reduced, there is a limitation on the 
number of replicates that can be included. Another approach using highly expressed control 
genes are often used to provide a normalization standard.  However, these constitutively 
expressed mRNA can vary between samples based on the physiological state of the cells from 
which they were extracted.  Another technique often used for determining spot morphology is to 
directly image spot density, which is proportional to the amount of light scattering provided by 
salt crystals in the printed spots.  However, the poor contrast of this method enables only an 
extremely coarse “score” to be applied to the data.  More importantly, the printed spot is not 
necessarily correlated with the bound target that remains after the wash step.  For the quantitative 
visualization of spotted probes, the incorporation of a third dye directly into the probe 40 or the 
use of imaging XPS on the array surface has been reported 41.  The first method can only be used 
for long immobilized sequences such as cDNA and is subject to a number of undesirable effects 
due to dye incorporation, while the second suffers from poor resolution and is not readily 
interfaced with the microarray assay format.  In order to overcome these limitations, photonic 
crystal label-free detection was proposed for microarray quality control and the results of this 
study are presented in a later chapter.    
Label-free (LF) detection can be implemented in schemes that probe some property of the 
target analyte, such is its mass (piezoelectric), electric charge (electrochemical), or dielectric 
permittivity (optical sensors) 42-43. Optical biosensors are especially attractive for two reasons. 
First, analyte binding events can be interrogated without any direct physical connection to the 
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sensor itself. Second, this class of sensors generally uses evanescent fields to probe the optical 
properties of a region that potentially contains the analyte of interest.  These evanescent fields 
decay exponentially and typically extend only a few hundred nanometers from the sensor 
surface, making it ideal for monitoring biochemical interactions at the surface of a sensor 
structure while minimizing the contribution of bulk solution effects. Many optical sensing 
modalities have been demonstrated, including ellipsometry, integrated waveguide sensors, 
resonant mirrors, and several others 44-48.  Especially notable is a technique utilizing surface 
plasmon resonance (SPR) which has been the basis of a popular commercial biosensor (Biacore, 
GE Healthcare). SPR is a very powerful tool, but has two important limitations: (a) it is 
unsuitable technique for large-format assays, and (b) in an imaging mode, it has limited spatial 
resolution due to the large propagation distance of surface plasmons which is on the order of 100 
microns. Elsewhere, an interferometric label-free imaging technique that tracks changes in the 
optical thickness of a biolayer due to a binding event has been applied to microarrays with 
promising results 49.  
As part of this dissertation, a PC-based LF detection method has been developed for 
generating images of a DNA microarray for the quantitative assessment of spot quality. Shifts in 
the PC resonant angle, which are proportional to the amount of biomaterial deposited on the PC, 
have been used to quantify the density of biomolecules deposited on the surface.  Because 
resonant light is not allowed to propagate laterally across the PC surface, it is possible to 
generate high resolution spatial maps of adsorbed biomolecular density by measuring the 
resonance shift as a function of position on the PC surface.  This spatial map of resonance shifts 
on a pixel-by-pixel basis is the LF image of the microarray and has been successfully used for 
spot quality analysis 50. Two key advantages of this PC-based LF modality are its adoptability 
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into standard microarray protocols without any modifications and the potential to combine this 
modality with PC enhanced fluorescence.  
 
1.3 Research outline 
 The overarching goal of this dissertation is to characterize improvements in microarray 
sensitivity through the application of PC enhanced fluorescence. To this end, the main area of 
focus has been the characterization of sensitivity improvements using PCs made on silicon and 
quartz using only materials with negligible autofluorescence. A second area of focus has been to 
determine the utility of spot quality analysis provided through PC-based, quantitative, label-free 
mass density information of microarray features printed for improving the quality of microarray 
data. An overview of the following chapters in this dissertation is presented below. 
Chapter 2 presents the findings of a study that employs a polymer-based PC 
configuration with a distinct optical resonance optimized for the purpose of quantitative, high-
resolution, label-free imaging of immobilized DNA spots. These spots are part of a 7,680 spot 
array, that when printed cover most of the area of a PC slide. Label-free images were acquired 
from multiple PC slides printed as part of different batches and the quantitative data will be 
utilized to identify and filter out low quality spots that reduce the accuracy of microarray data. 
In Chapter 3, work utilizing the second generation of quartz-based PCs designed for 
single wavelength and multi-wavelength fluorescence enhancement for improving the sensitivity 
of DNA microarrays is presented. The device designed for single wavelength fluorescence 
enhancement is engineered to have optical resonances aligned with the excitation and emission 
peaks for the Cyanine-5 (Cy5) fluorophore. These resonances are designed to enhance 
fluorescence through the two mechanisms of enhanced excitation and enhanced extraction. For 
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multi-wavelength fluorescence enhancement, the quartz-based PC was engineered to have two 
distinct resonances aligned with the excitation peaks for Cyanine-3 (Cy3) and Cy5 for enhanced 
excitation. A quartz-based PC structure is chosen specifically for its low autofluorescence 
properties relative to the first generation of polymer-based PC. Fluorescence intensity 
enhancement observed on the PC slide as compared to a standard glass slide, in the context of a 
DNA microarray will be evaluated. Gains in sensitivity as related to the ability to detect low 
expression genes on the PC that go undetected on the glass slide, will also be carefully studied. 
In Chapter 4, the latest generation of silicon-based PCs designed for fluorescence 
enhancement is presented as an alternative to the quartz-PCs. With the grating structure made 
only using TiO2 and thermally grown SiO2 - material with negligible autofluorescence - the 
advantage of the quartz-PCs are maintained in this fourth generation of silicon-based PCs. 
However, unlike the low throughput nanoimprint lithography fabrication process used to make 
quartz-PCs, these silicon PCs are fabricated using a foundry-compatible process flow that is 
amenable to the low-cost, high-throughput, and high uniformity fabrication of the PC grating 
structure over large areas. The optimized design, fabrication process, and optical properties of 
this newest version of the PC are presented along with the custom-instrumentation designed for 
optimal coupling to the resonant modes. The enhanced fluorescence performance of silicon-
based PCs and associated improvements in sensitivity afforded are characterized in the context 
of a small-area protein microarray and a micro-RNA (miRNA) microarray.  
The shift away from large-area DNA microarrays presented in Chapters 2 and 3 to 
smaller area microarrays in Chapter 4 has been made with the longer-term goal of developing a 
low cost, portable PCEF-based detection platform for blood-based biomarker detection in a point 
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of care settings. A discussion of this future direction along with some concluding remarks is 
presented in Chapter 5. 
Through the execution of the objectives of this dissertation, a case has been made for the 
usefulness of a PC-based sensing platform that both provides significant increases in the 
sensitivity of fluorescent microarrays as well as the label-free, quantitative information on the 
quality of printed microarray features. It is anticipated that the larger impact of improved 
reliability and sensitivity of the microarray technology will be in the area of rapid, low-cost, 
biomarker-based diagnostic tests. The direct and reliable detection of key biomarkers that are 
implicated in several disease states are often present in low-abundance at early stages of the 
disease, is a valuable capability that the PCEF-based detection platform is well poised to provide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1.4 Figures 
Figure 1.1 (a) A schematic of the fluorescence process. Absorption of a photon causes the 
molecule to jump from the ground state (S
Sn state, radiationless energy is lost as the molecule return to the S
to S0 is accompanied by the emission of fluorescence. (b) A schematic of competing processes 
that may also occur. These include (i) energy transfer to a nearby chromo
conversion to the ground state with no radiations (IC), or (iii) Crossing over to a triplet state 
followed by energy dissipation either via non
phosphorescence (ISC.) 
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0) to an excited energy state (S1 or Sn)
1 state. Reconversion from S
phore (ET), (ii) Internal 
-radiative or radiative pathways such as 
.If excited to the 
1 
  
Figure 1.2 (a) The excitation spectrum of Cyanine 3(Cy3) with a excitation peak wavelength of 
532nm. (b) Emission spectrum (in blue) for Cy3 alongside the excitation spectrum (red, dashed). 
Molecular structure for Cy3 is presented above the two spectral plots.
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Chapter 2: Label-Free DNA Microarray Imaging Using Photonic 
Crystals for Quantitative Spot Quality Analysis 
 
2.1 Chapter summary 
  
Microarray data has been shown to lack reproducibility 1, which in part is due to 
variability in array printing 2. Custom arrays that are printed in academic laboratories offer 
greater content flexibility and lower cost than commercial arrays, but are especially susceptible 
to variable print quality due to the absence of consistent quality analysis 3. Without robust quality 
control measures that account for this source of noise, the use of fluorescence spot intensity 
information for inferring gene expression levels - the underlying principle of microarray analysis 
- can be inaccurate. In this chapter, the use of a photonic crystal biosensor surface and a high 
resolution label-free imaging detection instrument to generate prehybridization images of spotted 
oligonucleotide microarrays is presented. Spot intensity, size, level of saturation, and local 
background intensity were measured from these images. This information was used for the 
automated identification of missed spots (due to mechanical failure or sample depletion) as well 
as the assignment of a score that reflected the quality of each printed feature. Missed spots were 
identified with >95% sensitivity. Furthermore, filtering based on spot quality scores increased 
pair-wise correlation of post hybridization spot intensity between replicate arrays, demonstrating 
that label-free spot quality scores captured the variability in the microarray data. This imaging 
modality can be applied for the quality control of printed cDNA, oligonucleotide and protein 
microarrays. 
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2.2 Motivation and background 
A high quality printed microarray slide possesses a uniform coating of a functional group 
that yields spots bound to the slide that are of desired density, shape, and size. Insufficient 
amounts of surface-bound probes can result in the underestimation or even complete failure of 
detecting gene expression 2, 4. In order to account for the variability that primarily stems from 
variable DNA probe deposition and retention on the slide surface, a few label-based methods 
have been devised for the visualization of printed slides prior to their experimental use. In one 
such approach, a labeled oligonucleotide target specific for a common vector sequence found in 
all immobilized probe spots has been used to visualize array spots 4. While this method provides 
information on each spot’s density and morphology, the analysis is performed on a single test 
slide sacrificed from each print batch which may not be equivalent to the slides used for the 
experiment. In another method, the probe spots are stained with an ssDNA-binding dye like 
SYBR Green II after printing 5. After visualization and quality analysis, these slides are 
destained before hybridization with the labeled target. The effect of this destaining process on 
subsequent slide performance can be a concern. A third approach that uses probes with cyanine-
compatible, fluorescein-labeled primers for visualizing cDNA-based microarrays and generating 
quantitative assessments of spot quality has been reported 6. However, the application of this 
method to spotted oligonucleotide arrays requires the labeling of each probe sequence, which is 
cost-prohibitive. As an alternative, the use of a fluorescein-labeled “tracking” oligonucleotide, 
introduced in the printing buffer at a low concentration for indirectly monitoring spot fidelity 
was developed 7. While this method can identify mechanical misses or spots where the target-
specific oligonucleotide was present at a very low concentration, it is not clear if the signal 
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dynamic range from the tracking oligonucleotide is sufficient for capturing the variability in 
concentration of the target-specific oligonucleotide for the remaining spots.  
Such label-based methods require the modification of immobilized probes or a change in 
typical microarray protocols limiting their widespread adoption. Here we use a photonic crystal 
(PC) biosensor based label-free (LF) detection method for generating prehybridization images of 
mass density for the quantitative assessment of spot quality. LF sensing is achieved by 
monitoring changes in the optical resonance condition of the PC as biomolecules with dielectric 
permittivity greater than the surrounding medium (air) are adsorbed to the surface.  By using a 
PC surface in place of a standard glass microscope slide to obtain spot information, this method 
can be applied to spotted cDNA, oligonucleotide, and protein microarrays alike, with no 
modification to standard spotting or hybridization protocols. 
 
2.3 Photonic crystal based label free imaging of DNA microarrays 
The PC is composed of a periodically modulated low refractive index nano-scale 
structure that is then coated with a high index dielectric layer, shown schematically in Figure 2.1. 
Such a device behaves as a narrow band optical filter with nearly 100% reflection (or 
correspondingly, ~0% transmission) when illuminated at a particular wavelength and incident 
angle combination, known as the resonant condition. For all other combinations, nearly 100% of 
the light is transmitted through the device. Since the structure consists of a grating with a 
subwavelength period, only zeroth order reflected and transmitted modes are propagated while 
higher order diffraction modes are cut off.  To excite the PC resonance while illuminating the 
device at a fixed wavelength, one modulates the angle at which the light is incident on the 
surface and generates a measurement of the PC transmission efficiency as a function of incidence 
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angle. Only a single incidence angle fulfills the resonance condition and nearly 0% transmission 
is observed at this angle. The resonant angle shifts to higher angles as the refractive index near 
the surface of the PC is increased by the adsorption of biomolecules. In this manner, the shift in 
the resonant angle can be used to quantify the density of biomolecules deposited on the surface.  
Because resonant light is not allowed to propagate laterally across the PC surface, the Angle of 
Minimum Transmission (AMT) at a particular location is independent of adjacent locations, so it 
is possible to generate high resolution spatial maps of adsorbed biomolecular density by 
measuring the AMT shift as a function of position on the PC surface.  As shown in Figure 2.2, 
the PC surfaces used in this study were designed and fabricated to provide a resonance at 
wavelength of λ=633 nm for an incident angle of ~2 degrees. Using plastic-based nanoreplica 
molding techniques described previously8, a continuous uniform PC surface is prepared on a 
flexible polyester substrate in a roll-to-roll manufacturing process and applied with adhesive to a 
standard 1x3 in2 glass microscope slide.  The entire microscope slide surface is comprised of the 
PC surface. 
LF images were captured using a custom high resolution imaging microscope described 
previously9. This instrument uses an angle-tunable, single-wavelength (λ=632.8 nm) laser source 
to illuminate (through the substrate) a PC that has been prepared with immobilized microarray 
capture spots.  While the PC is illuminated from below, a microscope objective and CCD camera 
gather a sequence of images of transmitted intensity from above the PC, where a sequence of 
images are rapidly gathered over a range of incident angles using small increments. From this 
stack of images, the resonant angle can be determined on a pixel by pixel basis by fitting the 
transmission versus angle data to a Lorentzian curve such that a label-free image of surface 
bound molecular density can be constructed.  This spatial map of resonant angles, called the 
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“AMT Image” is the LF image of the microarray.  A schematic diagram of the LF microscope is 
shown in Figure 2.3.   
We printed a custom 70-mer oligonucleotide array on PC surfaces and subsequently 
captured LF images. The arrays were then hybridized with a Cyanine-5 labeled target and 
fluorescence images were obtained. The LF images were used to generate quantitative 
information on spot characteristics such as morphology, surface DNA retention, and background. 
Using LF spot density information, a method was developed for the automated identification of 
missing spots in LF images in order to differentiate false negatives (due to a mechanical miss 
during printing or problem with the source well) from true negatives (due to the absence of gene 
expression). Next, to capture the variation in the probe density immobilized on the PC, a 
previously published microarray spot quality analysis method 2, designed for fluorescence 
prehybridization images, was adapted to our LF images. This algorithm was used to generate a 
composite quality score for each spot based on the following metrics: signal to background ratio, 
spot size and level of pixel saturation. These quality metrics have been shown to capture 
variability in the microarray data  wherein gene expression measurements from spots with high 
quality scores yield less variation than those made from low scoring spots 6, 10. We evaluated the 
use of these composite scores for quality filtering by comparing the reproducibility of unfiltered 
fluorescence hybridization data with data filtered based on spot scores. We found that filtering 
based on spot quality scores increased pair-wise correlation of post hybridization spot intensity 
between replicate arrays demonstrating that label-free spot quality scores captured the variability 
in the microarray data.  
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2.4 Materials and methods 
2.4.1 Device fabrication and characterization 
 
The PC devices used, shown schematically in Figure 2.1, were fabricated using a 
nanoreplica molding process as described previously 8. Briefly, a silicon “master” wafer with a 
negative volume image of the one-dimensional periodic grating structure was made using deep-
UV lithography and reactive ion etching. A liquid UV-curable polymer (UVCP) was dispensed 
on a polyethylene tetraphthalate (PET) sheet and the pattern from the master was transferred to 
the polymer with a roller. After the polymer was cured using a high intensity UV lamp, the 
replica was peeled away from the master. Next, an index matched 300 nm thick layer of SiO2 
was deposited via sputtering to act as a spacer between the autofluorescent UVCP layer and a 
high refractive index layer of TiO2. A 160 nm thick layer of TiO2 was finally sputtered on the 
device. The completed devices were cut into 25mm x 75mm sections and attached to glass 
microscope slides using an optically transparent adhesive. Optical characterization of the PC 
slides was performed by illumination with polarized, collimated white light and collection of 
transmitted light into a UV-visible light spectrometer (Ocean Optics).  To measure the dispersion 
of the devices and determine the angle of resonance, PC slides were mounted on an angle-
adjustable stage and rotated under illumination with broadband light polarized with an electric 
field vector oriented perpendicular to the grating lines. The transmission spectrum of a device as 
a function of angle is shown in Figure 2.2. The PC slides used in this study showed good spectral 
uniformity of the narrow excitation resonance over their area with a maximum observed resonant 
angle of σwithin-PC = 0.12o (corresponding coefficient of variance = 21.1%). Furthermore, we 
obtained label free images of silanized slides prior to printing. Figure 2.4 shows line profiles 
taken along the long axis of three PC slides used in this study.  
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2.4.2 Surface chemistry and array printing 
Due to its documented low autofluorescence 11, an epoxysilane-based surface chemistry 
was used to functionalize the PC slides. All slides were first cleaned in an O2 plasma system and 
then incubated overnight with 3- glycidoxypropyltrimethoxysilane at 185 mTorr. 
Oligonucleotides were printed on the slides using a Genetix QArray2 contact pin-spotter. A set of 
192 70-base oligonucleotides consisting of soybean genes annotated as storage proteins, cell wall 
proteins, transcription factors, and other genes of interest were spotted on the slides. These 192 
oligonucleotides are part of a larger set of 38,400 oligonucleotides detailed previously 12.  A total 
of six slides from two separate surface chemistry and printing batches were used in this study. 
The data pooled from all slides consisted of 32,640 spots of which 1300 were buffer blank spots 
used as negative controls.  
2.4.3 Label-free image acquisition and processing  
After rinsing any unbound DNA, label-free images of the printed PC slides were obtained 
using a custom built imaging microscope. A detailed description of the instrument and its 
operation has been presented previously 9 and is briefly discussed here. Label-free detection was 
performed by imaging the transmission of a transverse magnetic (TM) polarized (electric field 
perpendicular to the PC grating lines) and collimated 35 mW helium-neon λ=632.8 nm laser 
through the PC as a function of laser incidence angle. Images were captured using a 16-bit EM-
CCD (Hammamatsu, Japan) and the incidence angle was computer controlled and scanned for a 
fixed range of angles about the expected resonance location - typically between 0o and 3o, in 
increments of 0.01o. This transmission versus angle data was then fit per pixel to generate a 
label-free image at a pixel resolution of 8 µm. In this image, each pixel was assigned the fitted 
value for the angle of resonance. Using a 2x 0.06 NA objective (Olympus), the imaging system 
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gathers an AMT image from a 16mm2 area.  The system is capable of generating concatenated 
images of an entire microscope slide with a computer-controlled motion stage and software that 
can stitch together images from adjacent regions. Signal segmentation and spot intensity 
calculations of the label-free images were carried out using GenePix Pro 6.1.  Spot detection 
settings were chosen with a large scope (33-300%) of feature size, and without a minimum 
feature threshold, which means that no spots were eliminated at this stage.  This raw data for all 
spots was used for further analyses. 
2.4.4 Sample preparation and hybridization 
Soybean seeds (Glycine max cultivar Williams) with fresh weight between 100-200 mg 
were dissected to separate the cotyledon and then lyophilized. Using previously published 
protocols 12 , total RNA was extracted from the cotyledons.  The RNA sample was purified using 
a Qiagen RNeasy kit and labeled using a direct-label procedure with Cy5-dUTP. Approximately 
40 µg total RNA was used per slide. Slides were blocked prior to hybridization with Bovine 
Serum Albumin, hybridized at 42° C overnight with the labeled sample, and then washed.  
 
2.4.5 Fluorescence image acquisition and processing 
 
Post hybridization, all slides were scanned with a commercial confocal microarray 
scanner (LS Reloaded, Tecan) with a TM polarized laser (λ = 632.8 nm) at normal incidence.  A 
schematic of this scanner is provided in Figure 2.5. All slides were scanned at the same 
photomultiplier tube (PMT) gain and at a resolution of 10µm.  Signal segmentation and spot 
intensity calculations of fluorescence images were carried out using GenePix Pro 6.1.  Spot 
detection settings were chosen with a large scope (33-300%) of feature size, and without a 
minimum feature threshold.  The raw data for all spots except those flagged as “not found” by 
GenePix were used for further analyses.    
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2.5 Results and discussion 
A total of six PC slides from two separate surface chemistry and array print batches were 
used in this study. Pre-hybridization LF images of two sub arrays from a representative slide are 
shown in Figures 2.6 (a, b) and line profiles taken through these images are shown in Figure 2.6 
(c, d). It can be observed that areas where the probe DNA has been immobilized produce a 
measurable increase in the resonant angle.  
Each array was designed to include buffer blank spots as negative controls in 
predetermined locations across the slide. However, during visual inspection of the LF images, we 
noticed the presence of additional unintended missed spots (caused due to a mechanical failure or 
insufficient material in the source well) on slides from one of the print batches. Figure 2.6(a) 
shows a sub array containing intentional blanks spots while Figure 2.6(b) shows a different sub 
array on the same slide that contains missed spots. It is important to systematically identify and 
eliminate all such instances that result in false negatives in the post-hybridization expression data 
that is analyzed. Thus we sought to automate the identification of all missing spots in LF 
prehybridization images. First, all LF images were quantitated using the Genepix Pro 6.1 
software (Axon Instruments) to obtain spot intensity, background intensity and spot size 
information. Each spot was then assigned an intensity score, qintensity as follows:  
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where Smean = mean intensity of all pixels in spot, Bmean = mean intensity of all pixels in spot 
local background, and Smean0 = mean intensity of all spots in the corresponding sub-array. 
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The local background region is defined as the annular area around a spot that does not include 
any neighboring spots and has an outer diameter three times that of the spot. All pixels in this 
region contribute to the local background signal.  
For each spot, qsig-bkg is a measure of its density, qsig-sig0 is a measure of its intensity 
relative to all spots in the sub-array and both measures are values between 0 and 1. Our initial 
attempt to use only qsig-bkg to screen for missing spots was aborted due to the observed high false 
positive rate. This was due to spatial variations in the device resonant angle due to measurable 
surface chemistry gradients that increased spot background intensity, consequently reducing qsig-
bkg . To circumvent this problem, we developed the second measure, qsig-sig0 that compares the 
spot intensity to the mean intensity of all spots in the block. Using this measure, good spots 
located in regions of high local background were not penalized. A qintensity value approaching 1 
denotes a predicted present spot while a value approaching 0 denotes a predicted absent spot. 
Independently, images were visually inspected and each spot was manually classified into 
two categories (present, absent) by two users.  A spot that was classified as absent by either user 
was assigned to the “absent” category and all remaining spots were assigned to the “present” 
category.  
The qintensity for spots from all six slides were pooled and the prediction performance 
based on qintensity  was evaluated by receiver operating characteristic (ROC) analysis. The ROC 
curve shown in Figure 2.7(a) describes the ability of the parameter qintensity to discriminate 
between spots that are present and absent.  Using this curve, the threshold Tm =0.50 was 
identified to have with the highest prediction power (that is maximum specificity and 
sensitivity). Spots with qintensity below Tm were predicted as absent whereas the remaining spots 
were predicted as present. At Tm = 0.50, the sensitivity (absent spots predicted as absent) was 
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95.2% and the specificity (present spots predicted as present) was 98.5%. Of all identified true 
positives, 91.7% were intentional blank spots and 8.3% were unintentional missed spots. A 
density plot of the qintensity values for spots manually classified as absent and present is shown 
Figure 2.7(b). There exists a partial overlap in qintensity values between the two classes of spots. 
The threshold value Tm chosen represents the separation point between these categories that 
maximizes overall prediction accuracy. Our array was designed to contain a total of forty 
technical replicates per slide located on different sub-arrays in sets of five continuous replicates. 
We found that in many cases of unintentional missed spots, all five replicate spots in a sub-array 
were missed. For all instances of missed spots, we pooled prehybridization LF spot intensities 
and posthybridization fluorescence spot intensities from all forty replicates and the pooled data 
from two cases are shown in Figure 2.8. In such situations where all local replicates are affected, 
the prehybrization image allows us to identify and isolate the problem. 
Previous reports have shown that variability in pre-hybridization spot-level intensity, 
size, and shape irregularities, interrogated using fluorescence methods, influences the accuracy 
of post-hybridization expression measurements 2, 6, 13. Based on these observations, a quality 
measure for every spot was developed and filtering based on this quality score was shown to 
improve consistency in replicate hybridization pairs. We similarly sought to evaluate the impact 
of spot variability, as measured in our LF images, on our one-color post-hybridization 
fluorescence measurements, by adapting this composite quality scoring method.  
Spot quality was evaluated on the basis of three parameters as explained briefly. 
Spot size: The measure qsize assesses spot size irregularity. Spots larger than the usual size are 
penalized as this may indicate the presence of contaminants near the spot or that the spot is very 
close to its neighbors while smaller spots can imply high variability in local background. Size 
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irregularity can also imply that the printing and/or slide conditions were not optimal. This 
measure is defined as 

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q ………………………………………………..Equation 2.5 
where Spixel = number of pixels per spot, Spixel0 = average number of pixels per spot (computed 
for each array) 
Spot signal intensity: qsig-bkg is a measure of spot density as defined previously in Equation 2.2.  
Spot saturation: qsat is a measure of pixel saturation in a spot and is indicative of the presence of 
contaminants that result in a strong intensity value. This measure is defined as: 
0=satq  elseSif sat ;10≥ 1=satq ……………………………………………..Equation 2.6 
where Ssat = percentage of saturated pixels in a spot.  
Each quality measure is a value between 0 and 1 and the combined score, qlf-com is defined as: 
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 ………………………………………...…….Equation 2.7 
 
Figures 2.9 (a), (b) show prehybridization LF images and Figures 2.9 (c), (d) show post 
hybridization fluorescence images of two sub-arrays from a slide. Examples of spots with high 
and low qlf-com scores are indicated in the images. 
 We selected a total of four replicate microarray slides, two from each print batch, to 
evaluate the effect of filtering based on the spot qlf-com measure. The evaluation was made by 
monitoring changes in the pair-wise correlation coefficient in mean fluorescence intensity 
measurements of replicate spots from replicate arrays. The mean fluorescence intensity 
measurements used here were not normalized or corrected for background and represent raw 
values. The correlation coefficients of the unfiltered data ranged from 0.57 to 0.96. We found 
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that by modulating the qlf-com threshold value, the correlation between replicate arrays was 
increased to a range of 0.65 to 0.96 (Table 2.1). These results indicate that lower correlation 
between replicates post-hybridization is caused in part by pre-hybridization spot quality 
variability and that quality filtering using LF images improves reproducibility between arrays.  
These quality scores can be utilized to define weights for quality-weighted gene expression 
analysis where the filtering of poor quality data is achieved through their diminished weights, 
with possible gains in measurement accuracy 14. 
In defining our spot cumulative quality score qlf-com, we did not include two additional 
measures presented previously10 that penalize spots with high variability in local background 
variability and spots with excessive high local background. This is because spatial variations in 
the resonant angle due to device imperfections and measurable surface chemistry gradients 
currently hamper our ability to make meaningful measurements of background variability that 
reflect the quality of a spot. To address this, the implementation of image registration software 
that will align and subtract LF images of the device before spotting from images after spotting to 
remove these non-stochastic sources of background variability is underway. 
 
2.6 Conclusions 
In this work we have utilized PC biosensors and a high resolution LF imaging detection 
instrument to generate prehybridization images of spotted DNA microarrays while following 
standard microarray protocols. Spot level intensity, size, pixel saturation, and local background 
information was obtained from these images and used for semi-automated microarray quality 
control. Missed spots from the printing process, which generate false negatives in microarray 
data, were identified based on spot intensity scores
 
with high accuracy (>95%) and excellent 
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specificity (>98%). Non-discrete quality scores were generated for remaining spots based on spot 
intensity, size, and degree of saturation. We found that variability among replicates was reduced 
by filtering on the basis of quality scores as demonstrated by higher correlation coefficients. 
These scores can be utilized as weights in subsequent analysis procedures. Such efforts to 
identify and reduce the variability introduced prior to hybridization by technical contributors on 
a slide-by-slide basis will allow microarray users to make more accurate measurements of the 
more important biological variability that is being studied. 
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2.7 Figures and tables 
 
 
Figure 2.1: Schematic of PC structure used for label-free imaging. 
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Figure 2.2: To characterize the optical properties of the PC, the transmission of TM-polarized 
broadband light through PC as a function of incidence angle was generated. Label-free imaging 
was performed using 632.8 nm HeNe laser light that was TM polarized. At this wavelength, the 
device resonance angle was at ~ 2 degrees.  
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Figure 2.3: Schematic of the label-free imaging instrument. 
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Figure 2.4: Line profile (along the long axis) of three PC slides functionalized with epoxysilane. 
The observed variability in the PC resonant angle was primarily due to non-uniformities 
introduced by the epoxysilane functional layer. Outliers represent particulate contaminants or 
localized device defects. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.5: (a) Simplified schematic of the key components in a confocal microarray scanner. 
(b) Schematic of the commercially available 
used in this work. 
38 
Tecan LS Reloaded confocal microarray scanner 
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Figure 2.6: LF images of two sub arrays from the same PC slide are shown in (a) and (b). The 
white dashed box in (a) denotes the location of a set of 20 intentional blank spots. A line profile 
running through a row containing 3 blank spot followed by 13 probe spots is shown in (c). The 
white dashed boxes in (b) denote locations of unintentional missed spots. A line profile running 
through a row in this sub array is shown in (d). The difference in background signal between sub 
arrays indicates spatial variations in the resonance angle that is a function of device and surface 
chemistry non-uniformities. Dark specks in the images are due to device imperfections. 
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Figure 2.7: (a) The ROC curve demonstrates the ability to discrimination between spots that are absent or present on the slide by 
using qintensity. Four threshold values, selected for their high true positive rate (or sensitivity) and low false positive rate (or 1-
specificity) as indicated in the figure are presented in the table. By selecting a qintensity threshold of 0.5 (where spots with qintensity <0.5 
are predicted as absent), the predication sensitivity and specificity were 95.2% and 98.5%, respectively. As shown in (b) there is a 
partial overlap between the qintensity distributions for the two classes and the threshold is the separating point between the classes. 
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Figure 2.8: The mean pre-hybridization spot intensity of 40 replicate spots is shown in (a). Nine of these replicates were missed spots 
as indicated by the red circles. This finding was corroborated by the post-hybridization fluorescence data (b) of the replicates where 
the same nine spots showed low intensity as indicated by the red circles. Results from another observed instance where 10 of 40 
replicate spots were missed are shown in (c) and (d). 
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Figure 2.9: Pre-hybridization label-free images (a,b) and post-hybridization fluorescent images (c,d) of two sub-arrays from a given 
slide with spots of differing quality. The white dashed box in (b) and (d) denote the location of a set of negative control (blank) spots. 
Open red squares denote spots with qlf-com > 0.75 while open dashed red squares denote spots with qlf-com <0.5.
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Table 1:  Correlation coefficients (r) from the pairwise comparisons of 4 replicate arrays. Arrays 
1 and 2 are from the first print batch while Arrays 3 and 4 are from the second print batch.  
Coefficient r for the unfiltered raw data is presented alongside data filtered on the basis of qlf-com 
scores. Three filtering thresholds were used and in each iteration spots below the threshold were 
eliminated. All values were significant at p < 0.001.
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Chapter 3: Multi-color Fluorescence Enhancement through Quartz-
based Photonic Crystals for improved microarray sensitivity 
 
3.1 Chapter summary 
While DNA microarrays are a platform for the highly parallel study of expression of 
several genes of interest, usually the fluorescence intensity of only high expression genes - a 
small fraction of all genes in a cell population - can be detected above the noise in the 
experiment. However, the profiling of low expression genes, many of which have important 
housekeeping functions, is of keen biological interest. To better quantify low abundance genes, 
nano-patterned structures that intensify the electric field intensity surrounding surface-bound 
fluorophores, and in turn, enhance the fluorescence from common microarray dyes have been 
pursued 1. But, unlike surface PCs, such structures are not fabricated using methods that can 
produce surfaces that are uniform over the areas necessary for microarrays comprised of 
thousands of capture probes, or in the format of standard microscope slides. Furthermore, since 
substrate auto-fluorescence is an important contributor to the experimental noise in a microarray, 
the choice of this material is critical. In this chapter, we present how these three important 
fabrication considerations have been addressed by making PCs, designed for Cy5 fluorescence 
enhancement, on low fluorescence quartz substrates and how they have been successfully 
integrated with traditional microarray protocols to significantly increase the dynamic range of 
such experiments. Furthermore, this is the first demonstrated application of a quartz-based PC 
designed for multi-wavelength fluorescence enhancement in the context of a two-color (Cy3 and 
Cy5) DNA microarray experiment. Using a commercial fluorescence microarray scanner, 
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average signal enhancement factors of 14.9-18.3x were observed on the PC. Furthermore, twice 
as many genes were detectable on these PCs as compared to glass. By improving the sensitivity 
of this fluorescent assay, low expression genes that were undetectable on glass were quantified 
on the PC. An even higher signal enhancement of 22.2x was recorded on the quartz PC when a 
custom-built microscope was used to optimize PC resonance coupling on a pixel-by-pixel basis. 
By acquiring fluorescence images over a small range of incident angles centered on the device 
resonance, the fluorescence enhancement is maximized per pixel across the area of the image 
frame. 
 
3.2 Quartz-based photonic crystals for single and multi-wavelength 
fluorescence enhancement 
The PC used here is composed of a one-dimensional periodic structure formed on a low 
refractive index quartz surface that is coated with a high refractive index layer of TiO2. This 
periodic modulation in refractive index along the device surface gives rise to optical resonances 
when the device is illuminated at a particular wavelength and incident angle combination. When 
optical resonances are spectrally overlapped with the excitation and emission wavelengths of a 
fluorophore, they enhance the optical fields near the surface of the device and also spatially bias 
fluorescence emission for optimal collection. These two resonances, working through two 
distinct mechanisms, are combined to produce a multiplicative fluorescence signal enhancement 
2
. The PC design for Cy5 fluorescence enhancement utilizes two such resonances for a 
multiplicative fluorescence enhancement. The PC design for simultaneous Cy3 and Cy5 
fluorescence enhancement utilizes distinct resonances that are spectrally overlapped with the 
peak excitation wavelengths for the two fluorophores. These peaks only produce enhanced near 
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field electric fields for amplified fluorophore excitation. 
For the quartz PCs engineered to enhance Cyanine 5 (Cy5) fluorophore emission, the 
geometric parameters of the device were first determined using Rigorous Coupled-Wave 
Analysis simulations (DiffractMOD, RSoft Design Group, Inc.) such that the device resonant 
modes were aligned to the excitation and emission wavelengths of the Cy5 fluorophore. 
Specifically, these PCs have a transverse magnetic (TM) polarized (corresponding to an electric 
field vector oriented perpendicular to the grating) resonant mode at the Cy5 absorption peak 
λexcitation = 632.8 nm that amplifies fluorophore excitation by enhancing the near-field 3. 
Furthermore, these devices have a second TM mode close to λemission = 690 nm that lies in the 
band of emission wavelengths for Cy5. This second TM mode applies a spatial bias to the 
fluorophore emissions to maximize light collection 4. The schematic of the quartz PC design 
optimized to have two TM modes that enhance the fluorescence from Cy5 is shown in Figure 
3.1(a). 
In order to support resonances at λ=532nm (absorption peak wavelength of Cy3) and 
λ=632.8nm (absorption peak wavelength of Cy5) concurrently, the simulation results stipulated 
the use of the same overall grating structure as illustrated in Figure 3.1(a) but with an altered 
period of 360nm, grating depth of 60nm, and a duty cycle of 67%.  These devices, engineered for 
multiwavelength fluorescence enhancement anywhere in the 530-650 nm range, were designed 
to have TM polarized resonant mode at 582 nm when the device is illuminated at normal 
incidence. Due to the photonic band structure of such a device (Figure 3.2), two TM resonant 
modes, aligned with the Cy3 and Cy5 absorption peaks, also exist at illumination angles of 10.9 
degrees and 11 degrees off normal, respectively. These resonant modes when excited, amplify 
fluorophore excitation by enhancing the near-field electric fields.  
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The application of quartz PCs designed for Cy5 fluorescence enhancement to a 1-color 
DNA microarray that profiles genes expression in cotyledon tissue from soybeans is presented 
and improvements in assay sensitivity with the PC as compared to a control glass slide are first 
discussed. Second, a PC designed for Cy3 and Cy5 fluorescence enhancement is applied to a 2-
color DNA microarray profiling a mixture of two identical cotyledon tissue samples – one 
labeled with Cy3 and the other labeled with Cy5. For these fluorescence performance 
characterizations, both PCs and glass slides were imaged using a commercial, confocal laser 
scanner equipped with the capability to change the angle of incident light; to excite the relevant 
PC resonance, the incident angle was adjusted to match the device resonant condition. Finally, 
we demonstrate further improvements in fluorescence enhancement by employing an angle-
tuned fluorescence scanning modality which allows for optimal PC resonant excitation on a 
pixel-by-pixel basis. This scanning modality, afforded by a custom-built fluorescence 
microscope, allows us to better tolerate variability in PC resonance angle across the area of the 
device that typically arises from non-uniformities in surface chemistry and capture spot density. 
By scanning over a small range of angles centered on the device resonance, the fluorescence 
enhancement is maximized on a pixel basis across the area of the image frame. 
 
3.3 Experimental section 
3.3.1 Device fabrication and characterization 
The quartz PCs were fabricated using a step-and-flash nanoimprint lithography technique 
as described previously 5. Briefly, a template with the negative grating pattern was prepared over 
a 9 x 9 mm2 area using electron beam lithography. Quartz wafers (diameter, 4 in.) with ultra low 
auto-fluorescence were cleaned, planarized, and prepared for imprint by dispensing a uniform 
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layer of an imprint resist. The imprint process was then performed (Imprio-55, Molecular 
Imprints, Inc.) where the template was slowly pressed against the resist and the resist was then 
cured by UV exposure.  The template was then released by employing a pulling force to reveal 
the transferred grating pattern on the resist layer and this step-and-flash process was repeated to 
cover the entire wafer surface. Finally, a set of precisely timed reactive ion etching steps were 
performed to transfer the imprinted pattern into the quartz substrate. The wafer was then cleaned 
to remove any residual resists, diced into standard microscope slides (1 x 3 in2.), and fabrication 
was completed by sputtering a ~160 nm thick layer of TiO2 on the slides. 
The surface characteristics of the finished PCs were profiled with an atomic force 
microscope (AFM) (Dimension 3000, Digital Instruments) to compare the device experimental 
dimensions to the initial design parameters. Scanning electron microscope (SEM) images were 
also obtained to examine the cross sectional profile of the device. Next, the optical properties of 
the PCs, mounted on an angle-adjustable stage, was obtained by illuminating them with TM 
polarized, broadband light and collecting the transmitted light with a UV-visible light 
spectrometer (Ocean Optics). The transmission spectra of the TM modes that support 
fluorescence enhancement of Cy5 and Cy3 were obtained for the two different device types. For 
each device, the resonant angles (θexcitation) for these off normal TM modes of interest were also 
determined. 
3.3.2 Microarray printing and hybridization 
The PC slides were functionalized with an epoxysilane-based surface chemistry described 
previously 6. Commercially silanized glass slides (Corning GAPS II) were used as control slides 
in the microarray experiments. A previously reported 7 set of 192 oligonucleotides consisting of 
soybean genes were printed in replicates of 40, for a total of 7680 spots per slide. The 70-mer 
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oligonucleotides were printed (QArray2, Genetix) on PCs matched with glass control slides. 
Printed slides were incubated overnight and then UV crosslinked. Cotyledon RNA was extracted 
from freeze dried soybeans seeds (Glycine max cultivar Williams). The total RNA, extracted 
from the separated cotyledons, was purified and labeled with Cy5 by reverse transcription, for 
one-color microarray experiments. The printed slides were blocked with bovine serum albumin 
and then hybridized overnight at 42oC. In the case of two-color experiments, identical aliquots of 
the purified RNA were separately labeled with Cy5 or Cy3 by reverse transcription. Slides were 
then hybridized overnight with a solution made from equal parts of Cy3 and Cy5 labeled 
transcripts. Approximately 40 µg of total RNA was used per slide. All slides received identical 
treatments throughout the assay. 
3.3.3 Fluorescence data acquisition and analysis 
PC and glass slides were scanned using a confocal microarray scanner (LS Reloaded, 
Tecan) using a TM polarized laser (λ= 632.8nm) and an emission filter with a range of 670-710 
nm. All slides were scanned at identical PMT gain settings and at a pixel resolution of 10 µm. 
PCs were scanned at their respective resonant angles (θexcitation) while glass slides were scanned at 
normal incidence (0 degrees). 
3.3.4 Angle tuned fluorescence acquisition 
In order to obtain precisely resonant angle-tuned fluorescence data, a custom built 
enhanced fluorescence (EF) microscope system, described here 8 was used (instrument schematic 
in Figure 3.3). This system has two salient features that allows for the optimal excitation of the 
PC resonance over the area of a microarray. First, the instrument uses collimated, laser 
illumination to provide the most efficient coupling to PC resonance 8. Second, the angle of 
incidence can be controlled by a high-precision angle-tuning mirror allowing for a pixel-by-pixel 
optimized excitation of the PC resonance. It should also be noted that rather than scanning the 
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PC surface, this system captures an image of an entire field of view at once.  This microscope 
consists of the following key components:  a 35 mW HeNe laser, ( λ = 632.8 nm) that is TM-
polarized with respect to the PC grating lines; a beam expander is used to produce an 
illumination spot with a diameter of 4 mm and divergence angle of 0.037 °; a rotating diffuser is 
used to reduce speckle and fringes at the imaging plane by randomizing the spatial coherence of 
the laser; a high-precision angle-tuning gimbal-mounted mirror with a resolution of 0.005 ° 
incident angle increments; an electromultiplying charge-coupled device (Hammamatsu, Japan) 
through a 4 × microscope objective (N.A. = 0.1); a band-pass filter (Semrock, λ = 690, ∆λ = 20 
nm) that overlaps with the emission bandwidth of the Cy5 to prevent photons at the excitation 
laser wavelength from reaching the CCD during fluorescence imaging.  
Spot segmentation and intensity calculations of all fluorescence images were performed 
using Genepix Pro 6.1 (Molecular Devices, Sunnyvale, CA). Spot SNR was calculated as the 
local background subtracted spot intensity divided by the standard deviation of the local 
background. The local background region is defined as the annular area around a spot that does 
not include any neighboring spots and has an outer diameter three times that of the spot. All 
pixels in this region contribute to the local background signal.  
 
3.4 Results  
The schematic of the quartz PC design optimized to have two TM modes that enhance the 
fluorescence from Cy5 is shown in Figure 3.1(a). A representative cross-sectional image of the 
finished device was obtained using a scanning electron microscope (see Figure 3.1(b)). The 
surface profile of the PC, obtained using an AFM showed good agreement in dimensions 
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between the fabricated devices and this design (see Figure 3.1(c)). A completed PC that has been 
diced to the dimensions of a microscope slide is presented in Figure 3.1(d).  
A PC resonance can be excited by varying either the wavelength or the angle of the 
illumination that is incident on the device. The transmission spectra of a PC designed to enhance 
Cyanine-5 fluorophore emissions is presented in Figure 3.4(a) and indicates the presence of two 
narrow PC resonances of interest obtained at two different illumination angles. At an 
illumination angle (θexcitation) of 9o, there exists a resonance at the Cy5 excitation peak of 632.8 
nm. A second resonance, centered at a wavelength of 696 nm, was obtained at normal incidence 
and overlaps the Cy5 emission filter band. The transmission spectra of the PC optimized both for 
Cy5 and Cy3 fluorescence enhancement is presented in Figure 3.4(b). Such a device, when 
illuminated with incident light at an angle of 10.9 degrees has a resonance peak aligned with the 
Cy3 excitation peak at 532 nm. At an illumination angle of 11 degrees, the PC resonance aligned 
with the Cy5 excitation peak of 632.8 nm is excited. 
Post-hybrization fluorescence images of a sub-array from a 1-color DNA microarray on 
the PC at resonance and a glass slide, obtained using identical scan settings (photomultiplier tube 
gain, scan resolution) and contrast-adjusted to maximize feature visibility are presented in 
Figures 3.5 (a,b) and depict observed spot fluorescence intensity enhancements on the PC. In this 
1-color experiment, total RNA from soybean cotyledon samples (Glycine max cultivar Williams) 
was purified, labeled with Cy5 by reverse transcription was used to hybridize the microarray. 
Not only are signals from high expressing genes enhanced on the PC (Figure 3.5(c)), but several 
low expressors that cannot be differentiated from the background noise on the glass slide are 
detectable on the PC at resonance (Figure 3.5(d)). All 40 replicates of each gene were averaged 
and a ratio of the average background subtracted spot intensity on the PC at resonance to that off 
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resonance was calculated for each gene. Across the full set of 192 genes in this microarray, an 
average spot intensity enhancement of 17.8x was observed on the PC as compared to the glass 
slide. The impact of spot intensity enhancements was observed in SNR enhancements and the 
increased number of genes that were detectable on the PC at resonance as compared to off 
resonance. An average SNR enhancement of 3.8x was recorded. Here, a gene was defined as 
detectable if the replicate-averaged gene SNR was greater than 3. As shown in Figure 3.6, only 
26 genes of all genes (13.5%) were detectable on the glass slide while, 51 genes (26.6 %) were 
detectable when the PC resonance was excited. In comparing a set of PCs against their paired 
glass slides, an average of twice as many genes was detectable on the PC. 
Fluorescence images of a sub-array from a 2-color DNA microarray experiment on a PC 
device engineered to enhance the excitation of Cy3 and Cy5 fluorophores is presented in Figure 
3.7(a, b). In this dual-color experiment, two identical aliquots of total RNA from soybean 
cotyledon samples (Glycine max cultivar Williams) where labeled with Cy3 and Cy5 
respectively via reverse transcription, mixed together, applied to the PC and incubated overnight 
at 42oC for the DNA hybrization step. Line profiles through a row of spots on the Cy3 and Cy5 
channels are presented in Figure 3.7(c,d) for both the PC at resonance and the corresponding 
control glass slide in this pair. For the Cy3 channel, a replicated-averaged spot intensity 
enhancement of 14.9x across the set of 192 genes was observed on the PC as compared to the 
glass slide. On the Cy5 channel, an average spot signal enhancement of 18.3x was observed. 
Average SNR enhancements 3.4x and 3.7x were observed on the Cy3 and Cy5 channels, 
respectively. 23 genes (11.9%) were detectable on the glass slide on the Cy 3 channel while, 56 
genes (29.2%) were detectable when the PC resonance centered at 532nm was excited. On the 
Cy5 channel, 28 genes (14.6%) were detected on the glass slide while 59 genes (30.7%) were 
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detected on the PC at resonance.  
 PC-enhanced excitation is highly sensitive to the resonant angle for collimated 
illumination as previously reported 8. With a device full-width at half maximum (FWHM) of ~ 
0.4 degrees, small deviations in illumination angle from the actual resonant angle can result in 
significant drops in the signal enhancement. Variability in surface chemistry and capture spot 
densities across the area of a PC slide are important contributors to deviations in the PC resonant 
angle across the assay area 9. To account for such existing variations in the PC resonance angle, 
we applied an angle-tuned illumination process that is designed to achieve the maximum 
fluorescence enhancement for each spot 10. Here, rather than using a single fixed angle to scan 
the entire array, a series of 100 fluorescent images were captured for incident angles in the range 
of 10.5 ° < θ < 11.5 ° at an angle increment of ∆θ = 0.01 °. Using the 4× objective on the EF 
microscope, 2 x 2 mm2 image frames were obtained. Two such adjacent frames were stitched 
together to construct the fluorescence image of one complete sub-array containing 160 spots (32 
genes, 5 replicate spots). The maximum intensity values for each pixel are used to generate a 
composite fluorescent image in which each pixel is represented at its optimal on-resonance 
coupling condition. For the purpose of comparison, a single fixed angle scan of a sub-array on a 
control glass slide was paired to the angle-scanned fluorescence data for that same sub-array on a 
PC slide. Figure 3.8(a) presents the angle-tuned and fluorescence maximized image of one such 
sub-array on a quartz PC that is designed for Cy5 fluorescence enhancement.  
Across the set of 160 spots in this sub-array, an average signal enhancement of 22.2x was 
observed for the angle-tuned, resonant fluorescence output from the PC when compared to the 
single, angle scan on the control glass slide. Furthermore, an average SNR enhancement of 5.7x 
was recorded on the PC. This compared very favorable to the signal and SNR enhancements 
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observed when the PC was scanned using the commercial confocal laser scanner at a single 
incidence angle close to the device resonance but not optimized on a pixel-by-pixel basis. For 
these fluorescence scans of the same sub-array made on the identical PC-glass slide pair used 
previously, an average signal enhancement of only 7.39x and SNR enhancement of only 2.44x 
was observed. Figure 3.8(b) illustrates a comparison of the observed fluorescent enhancement on 
a spot-by-spot basis for the angle-tuned acquisition (using the EF microscope) and for a fixed 
angle acquisition (using a microarray scanner). We attribute these observed improvements in 
signal and SNR enhancement factors to the improved ability to more accurately excite the PC 
resonance on a pixel-by-pixel basis using the EF microscope. 
 
3.5 Discussion 
Many of the highly expressed genes, detected both on the glass and PC, encode storage 
proteins which are abundant during this stage of seed development. The additional genes 
detected only on the PC represent enzymes and important regulatory transcription factors that are 
expressed at lower levels. Transcription factors provide genetic control over development and 
can also be important markers of disease state. The ability of the PC to detect these low 
abundance transcripts is reflected by the lower average fluorescence intensity of 515 counts for 
genes detected only on the PC as compared to an average fluorescence intensity of 3280 counts 
for genes detected on glass.  
The quartz based PCs used in this work offer some unique advantages for DNA 
microarray applications over previously reported work using PCs based on plastic substrates with 
polymer gratings. Substrate auto fluorescence is an important source of noise in a microarray 
experiment, and increases when illuminated with higher energy (or lower wavelength) photons. 
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The quartz PCs have a substrate fluorescence that is 15 times lower than plastic PCs. This is an 
important consideration when designing a PC to enhance fluorescence emission from Cyanine-3 
(Cy-3, λexcitation = 536 nm), another fluorophore that is routinely used in DNA microarrays. 
Devices fabricated on low-fluorescence quartz substrates, designed for multiple fluorophore 
enhancements and successfully applied to 2-color DNA microarrays have been presented here 
for the first time. Finally, we have shown that by using an angle-tuned illumination approach to 
better tolerate angular variability in the PC resonance over the device surface that arises from 
non-uniformities on the PC surface that arise from the surface functionalization and capture spot 
immobilization step, the fluorescence enhancement can be maximized on a pixel-by-pixel basis. 
This image acquisition modality was realized with a custom-built microscope and provided a PC 
signal enhancement compared to a control glass slide that was 3x higher than the enhancement 
recorded using a fixed-angle illumination with a commercial fluorescence scanner. 
In conclusion, we have demonstrated that PC enhanced fluorescence using quartz 
substrates have significantly improved the sensitivity of a 1-color and 2-color DNA microarray. 
Over twice as many genes were detected over substrate noise on the PC compared to standard 
glass microarray.  
 3.6 Figures 
Figure 3.1 (a) Schematic of a PC for Cy5 fluorescence enhancement with device dimensions.
50%, grating depth = 40 nm, TiO2 thickness = 160 nm. (b) SEM image of a device cross section (c) AFM surface profile of a 
completed PC (with TiO2) with a measured grating period of 402 nm and a grating depth of 44 nm. (d) Image of a quartz PC diced to 
the dimensions of a microscope slide (1 x 3 in2
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.) 
 
  
Figure 3.2 Simulated dispersion diagram for a quartz
fluorescence enhancement and illuminated with TM polarized, collimated light. Resonance peaks 
for Cy5 and Cy3 excitation are at incident angles of ~4.5 degrees and ~6.1 degrees, respectively.
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Figure 3.3 Schematic of the EF microsc
source fitted with a polarizer and beam expander; a 
capable of scanning the incident 
mm
2
 field of view of the PC. The 
PC for EF detection.
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Figure 3.4 (a) Optical transmission measurements of a quartz PC when illuminated with TM polarized and collimated white light at 
two different incidence angles. When illuminated at an incidence angle of 9 degrees, there exists a resonant mode (red) that overlap
the Cy5 excitation wavelength of 632.8nm (blue line). For normal incidence illumination, there exists a resonant mode (black)
overlaps the Cy5 emission filter wavelength range of 670
Cy3 and Cy5 fluorescence enhancement. At excitation angles of 10.9 degrees and 11 degrees, there exists PC resonances centere
532nm and 632.8nm, respectively and aligned with the Cy3 and Cy5 excitation wavelengths.
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Figure 3.5 Fluorescence images of a subarray obtained using a microarray scanner at identical microarray gain settings on  a PC at 
resonance (a) and a glass slide (b). Contrast and brightness has been optimized on each image to maximize feature visability. Line 
profiles (c) and (d) show examples of signal enhancement of high and low expression genes, respectively.
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Figure 3.6 Logarithm (base 3) values of replicate-averaged SNR for all 192 genes on the PC (a) and glass (b). Genes with SNR > 3 or 
correspondingly log 3(SNR) > 1 are classified as detected. 51 genes were detected on the PC while only 26 were detected on the 
control glass slide. 
 Figure 3.7 Fluorescence images of a subarray on a PC designed for Cy3 and Cy5 fluorescence enhancement. (a) PC resonance 
centered at 532 nm has been excited (b) PC resonance centered at 632.8 nm has been excited. Images obtained using a 
scanner. Line profiles (c) and (d) show examples of signal enhancement on the two channels when compared to the paired glass 
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microarray 
slide. 
 Figure 3.8 (a) An angle-tuned fluorescence image of a subarray on a PC. By acquiring fluorescence im
centered around the device resonance, resonant coupling to the device is optimized on a pixel
enhancement. Such a scanning modality resulted in higher signal enhancement on the PC versus glass w
fixed-angle scanning scheme adopted on the microarray scanner. A spot
two scanning modalities is presented in (b) for a row of spots enclosed in the yellow rectangle in (a)
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Chapter 4: Sensitive Cancer Biomarker Detection Using Photonic 
Crystal Enhanced Fluorescence on a Silicon Substrate 
 
4.1 Chapter summary 
Using the multiplicative effects of optical resonant coupling to the PC in increasing the 
electric field intensity experienced by fluorescent labels (“enhanced excitation”) and the ability 
of a photonic PC optics (“enhanced extraction”), PC enhanced fluorescence (PCEF) can be 
adapted to reduce the limits of detection of disease biomarker assays, and to reduce the size and 
cost of high sensitivity detection instrumentation.  In this work, we demonstrate the first silicon-
based PCEF multiplexed biomarker assay.  The silicon-based PC structure, comprised of a SiO2 
grating that is overcoated with a thin film of high refractive index TiO2, is produced in a 
semiconductor foundry for low cost, uniform, and reproducible manufacturing.  We have also 
designed, built, and demonstrated a compact detection instrument that efficiently couples 
fluorescence excitation from a semiconductor laser to the resonant optical modes of the PC, 
resulting in elevated electric field strength that is highly concentrated within the region <100 nm 
from the PC surface.  The instrument utilizes a cylindrically focused line to scan a microarray in 
<1 minute.  The microarrays used in this work were produced by spotting capture antibodies and 
miRNA by Dip Pen Nanolithography, enabling arrays to be small enough to be performed easily 
with a 10 µl test sample. To demonstrate the capabilities of the system, microspot fluorescent 
sandwich immunoassays using secondary antibodies labeled with Cy5 for two cancer biomarkers 
(TNFα and IL-3) were performed. Biomarkers were detected at concentrations as low as 0.1 pM. 
In a fluorescent microarray for detection of a breast cancer miRNA biomarker, the miRNA was 
detectable at a concentration of 0.6 pM.  
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4.2 Motivation for blood-based cancer biomarker detection 
Circulating blood contains a diverse set of cellular and molecular elements that can be 
detected and quantified to indicate the presence of cancers, allergies, heart disease, and 
neurodegenerative disease 1-10. The detection of bloodborne biomarkers has value not only for 
disease detection, but also for informing the prescription choice for personalized therapies and in 
the monitoring of these treatments. For example, biomarker levels can help assist the 
development of novel molecular-targeted therapeutic strategies, identify patients who are likely 
to benefit from a specific targeted treatment, as well as provide molecular endpoints to predict 
and monitor treatment efficacy 11-13. Thus, the ultimate goal of such research is to reduce 
mortality rates through early disease detection and by administering novel targeted drug therapy 
in conjunction with a multiplexed, sensitive, rapid, and inexpensive biomarker-based monitoring 
system. 
In the most general sense, a biomarker is any measurable factor that differentiates a 
normal biological process from a disease-related process or its response to therapy. In the search 
for cancer biomarkers, the quantitative analysis of products of cancer cells, the tumor 
microenvironment, the host’s response, and the interaction between these three components has 
yielded several potential candidates. Circulating protein markers are currently in clinical use for 
the diagnoses of ovarian, pancreatic, colon, and prostate cancers 14-16. Exosomal microRNAs 
(miRNA), which are 18-24 bases long double stranded noncoding RNA that regulate expression 
through control over mRNA and protein translation, is another class of biomarker molecules that 
has been keenly studied as their expression is altered in disease states, notably in cancers 17-19. A 
special consideration for detecting cancer biomarkers is that tumors initially develop from a 
small population of defective cells, and hence it is highly desirable to be able to detect the 
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presence of the smallest number of tumor cells (i.e. early intervention) when a patient’s clinical 
outcomes and prognosis are still favorable. Although reports of several bioanalytical techniques 
for cancer biomarker detection exist, an unmet, critical limitation is the reliable and accurate 
detection of cancer biomarkers mainly due to (a) insufficient sensitivity of the assay and (b) 
insufficient dynamic range needed to detect biomarkers anywhere from the low ng/mL to the low 
pg/mL range 20. 
 Because single biomarkers often have inadequate predictive value, reliable cancer 
detection and monitoring platforms typically must include a biomarker panel 11, 14, 21-25. 
Multiplexed biomarker detection increases the predictive power through statistical and 
biochemical means to reduce false positive and false negative results 21, 23, 26-27. 
 To maximize the applicability and accessibility of a biomarker detection platform, the 
ability to perform sensing noninvasively is highly desirable, particularly if it can utilize a sample 
comprised of a single droplet of blood.  The adoption of biomarker tests will be further 
accelerated by methods that can be performed with minimal sample preparation and technical 
expertise, potentially enabling testing to be performed in close proximity to the patient. Such a 
portable platform would help reduce costs, minimize sample degradation, provide on-spot 
diagnosis thus alleviating patient stress, and finally guide the course therapy especially when 
timely adjustments in treatment are critical.  Detection instruments used in a point-of-care setting 
must be inexpensive, compact, and rugged. 
With the above design considerations in mind, we present, for the first time, the ability to 
use a silicon-based photonic crystal (PC) surface to achieve pg/ml-level sensitivity for 
multiplexed cancer biomarker detection (soluble proteins and miRNA) using photonic crystal 
enhanced fluorescence (PCEF) to amplify the output of surface-based fluorescent assays. Our 
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efforts focus on three core elements of the detection platform: the PC surface, the detection 
instrument, and the miniaturized biological assays. The PC surfaces are designed to provide 
optical resonances for efficient coupling to the excitation laser and efficient extraction of 
fluorescence emission on silicon substrates using SiO2 and TiO2 materials selected to provide 
negligibly low levels of autofluorescence, thus enabling weak fluorescent signals generated by 
low concentration analytes to be easily observed. Furthermore, the Si-based PC allows the sensor 
to be inexpensively, uniformly, and reproducibly manufactured in a semiconductor foundry.  The 
detection instrument was specifically designed so that all the light delivered by a miniature solid 
state laser can be coupled to PC resonant modes by taking advantage of a unique feature of the 
PC photonic band structure.  PC enhancement enables the use of inexpensive components to 
detect otherwise weak fluorescent signals, resulting in a compact and inexpensive line scanning 
instrument. In order to minimize the usage of capture molecules while simultaneously 
minimizing the size of the array, capture protein and oligonucleotide spots were printed using 
dip-pen nanolithography (DPN) and electrohydrodynamic jetting (e-jet) technologies.  
To demonstrate the capabilities of this system, microspot fluorescent immunoassays for 
two breast cancer biomarkers (TNFα and IL-3) were performed. Using only 10 µl sample 
volumes, consistent with detection from a droplet of fluid, the biomarkers were detected at 
concentrations as low as 0.1 pM. Finally, in a fluorescent microarray for detection of a breast 
cancer miRNA biomarker (miR-21), the miRNA was detectable at a concentration of 0.6 pM. 
Our long-term goal is to demonstrate a system that can be applied broadly for multiplexed 
soluble biomarker analysis particularly for diseases in which no accurate imaging modality 
exists, where imaging would be cost-prohibitive as an initial screen, or for situations in which 
noninvasive and frequent biomarker monitoring would be beneficial. 
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4.3 Methods 
4.3.1 Device design, fabrication, and surface characterization 
A commercially available simulation tool for rigorous coupled wave analysis 
(DIFFRACTMOD, RSoft) was used to aid in the optimal design of a PCEF device that provides 
maximal electric field enhancement for a TM mode at 632.8nm. Simulation results dictated the 
use of a structure with a period of 360nm, a duty cycle of 36%, a grating depth of 40nm, and a 
TiO2 thickness of 120nm. A schematic of the final device design is presented in Figure 4.1. 
The first prototype devices were fabricated in a university cleanroom setting using a 
nano-imprint lithography process that has been reported previously 28. Briefly, a thermal oxide 
with a thickness of ~ 800nm was first grown on a silicon wafer (4” diameter, double side 
polished). The wafer was then planarized by coating with a polymer (Transpin, Molecular 
Imprints, Inc.) and hard baked in preparation for the imprint lithography. The Step and Flash 
Imprint lithography (SFIL) process was carried out using the Imprio-55 (Molecular Imprints, 
Inc.) and an existing imprint template where the grating pattern was created in a 9 x 9 mm2 area; 
the template was created using electron beam lithography and reactive ion etching (RIE). First an 
imprint resist (Monomat, Molecular Imprints, Inc.) was dispensed onto the wafer in the requisite 
pattern to optimize the fidelity of the pattern transfer from the template. Next, the template was 
brought in contact with the resist dispensed on the wafer and the resist was cured with a short 
exposure to UV light. The template was then released and this SFIL process was repeated to 
cover the area of the wafer. After the imprint lithography was completed, three RIE steps were 
performed to transfer the imprinted pattern from the resist layers into the silicon oxide layer. The 
wafer was then cleaned to remove any residues of polymers that were used as etch masks. After 
cleaving the wafer into smaller pieces, fabrication was completed by sputtering a layer of TiO2 
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(thickness of ~ 120nm) over the grating. SEM images of these initial prototype devices are 
presented in Figure 4.2. 
While our nano-imprint lithography tool is well suited for prototyping, we were 
unsuccessful in using the tool to produce several full wafers in a university cleanroom setting. A 
commercial vendor (SVTC Inc., Austin TX) was contracted for the large scale fabrication of 
these devices over the area of 8” wafers. A thermal oxide (thickness of 800nm) was grown on 
each Si wafer and a deep UV photolithography process (193nm, ArF-line) was used to create the 
grating pattern in the oxide layer. For the lithography step, a 4X binary reticle (6” x 6” x 
0.25mm, quartz) with a critical dimension tolerance of +/- 0.05µm and uniformity of +/- 0.04µm 
was used. Precisely timed reactive ion etching steps were then used to transfer the grating pattern 
from the resist layer into the SiO2 layer. Scanning electron micrographs showing the surface 
characteristics of these PCs are presented in Figure 4.3(a, b). The wafer was diced to produce 1” 
x 0.5” chips that were then coated with TiO2 to complete the device. Additional images of a 
completed wafer and its surface characteristics are presented in Figure 4.4. 
4.3.2 Device optical characterization 
The success of PCEF is critically dependent on the ability of the detection instrument to 
effectively couple light into a PC. The degree of coupling plays a critical role in the enhancement 
factor achievable by a PC-instrument combination 29. The process of characterizing a PC 
involves the measurement of the wavelength spectra associated with the PC. This was done to 
ensure suitable positioning of the resonance reflection peak for the PC. The angle spectrum of 
the PC was then measured at a fixed laser wavelength. The percentage of transmitted light at the 
resonance condition was indicative of the coupling efficiency of the PC with the instrument. For 
this purpose, an angle-tuned reflection system was developed that allowed for the measurement 
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of the wavelength spectrum. The schematic of this setup is given in the supplemental section, 
Figure 4.5. The setup consists of a tungsten halogen lamp (white light), which is coupled to an 
optical fiber (Ocean Optics Inc.) with a 50 µm core. The output of the fiber is collimated using 
an achromatic lens. The white light is polarized using a linear polarizer (Thorlabs Inc.) and 
projected onto the photonic crystal device that is held in a customized holder. The setup design 
takes advantage of the 1-D PC’s relative insensitivity to angle change in the θ-direction. The PC 
holder is oriented at a fixed angle of θ = 5°. The detector is placed at distance of 150 mm from 
the base of the PC holder and tilted up by 2θ = 10°. This orientation allows for the detection of 
the reflected spectra at normal incidence. The detector height is lower than the height of the 
illumination beam and is composed of another collimator, which is coupled to a 50 µm core 
fiber. The other end of the fiber is coupled to a spectrometer (Ocean Optics Inc.). Utilizing 
commercial software (Spectra suite, Ocean Optics Inc.), we are able to measure the reflected 
spectrum. In order to measure the reflected wavelength spectra off normal, we mount the PC 
holder on a rotation stage. This stage is then mounted on a 180 mm custom arm that contains the 
detector mount at the other end. The arm is then sandwiched by another rotation stage. This is 
depicted in Figure 4.5. In order to measure the reflected wavelength spectrum at an angle of 
incidence ϕ, we rotate the top rotation stage by ϕ clockwise and the bottom stage by 2ϕ 
counterclockwise. This allows the detector to collect the reflected wavelength spectra at every 
angle. Each spectrum is normalized using a gold reflection mirror.  
4.3.3 LD-700 assay for fluorescence enhancement characterization 
 To characterize the fluorescence enhancement afforded by the silicon PCs, a fluorescent 
dye, LD-700 (Exciton, Inc., Dayton OH; excitation peak = 647nm, emission peak = 673nm) was 
used as previously reported 30. The dye was mixed with SU-8 which served as the carrier and this 
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solution was spun coated onto the device. SU-8 2000.5 was mixed with an SU-8 thinner 
(Microchem Corporation) at a ratio of 1:20 (by volume). The stock LD-700 dye solution was 
diluted in methanol to a concentration of 100nM (53.8 ng/mL). The LD-700 was then mixed 
with the thinned SU-8 solution in 1:1 ratio (by volume) and the resulting solution was spun 
coated on the silicon PC and control glass substrates (Spincoater P6700, 5000rpm, 30 seconds).  
4.3.4 Device surface functionalization 
The PC devices were functionalized using a vapor-phase epoxysilane process. The 
epoxysilane chemistry was chosen for its low background fluorescence 31 and high binding 
capacity to capture antibodies 32. The devices were first cleaned by sonication in 2” petri dishes 
of acetone, isopropanol, and deionozied (DI) water for 2 minutes each. The devices were then 
dried in a stream of N2 and then treated in an oxygen plasma system (Diener, Pico) for 10 
minutes (power of 100W, pressure of 0.75mTorr). The backside of each device was then adhered 
to the inside of a screw top lid of a 2” glass container. At the base of the container, 100uL of (3-
Glycidoxypropyl) trimethoxysilane (GPTS, Sigma Aldrich, Saint Louis, MO) was placed and the 
screw top lid was securely placed over the dish. After securely tightening the lids, each dish with 
a device adhered to its lid was placed in a vacuum oven for an overnight incubation at a 
temperature of 80 oC and a pressure of 30 Torr. The devices were then detached from the lids 
and sonicated in 2” petri dishes of toluene, methanol, and DI water for 2 minutes each and dried 
under a stream of N2.  Standard glass microscope slides that served as controls were also 
silanized using the same protocol but with appropriately sized glassware. 
4.3.5 SA-Cy5 microspot assay for fluorescence enhancement characterization 
To evaluate fluorescence enhancement, cyanine-5 (Cy5) conjugated streptavidin (GE 
Healthcare) at a concentration of 100µg/mL in phosphate buffered saline (PBS) with 60% v/v 
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glycerol was printed onto the substrates for a total of 14 replicate spots with a diameter of 
45±6µm. Protein spots were printed using an electrohydrodynamic jetting (e-jet) system 
previously introduced here 33-34 as a non-contact method for high resolution printing. The print 
head consists of a syringe acting as an ink reservoir that is then connected to an Au-Pt coated 
(thickness of ~10 nm), glass, luer-tipped micropipette nozzle (World Precision Instruments) with 
an inner diameter of 5µm. Through a combination of capillary force and an appropriately 
selected back pressure that is applied to the fluid, a spherical meniscus is formed at the tip of the 
nozzle. A voltage is then applied between the nozzle tip and substrate to draw the meniscus into 
a cone and jetting from this cone creates printed features on the substrate. By modulating three 
parameters - the back pressure, the separation distance between the nozzle and substrates, and the 
applied voltage, one can modulate the jetting frequency and droplet size. A pulsed-voltage mode 
with a square-wave function was used to create lines of droplets to form arrays. 
After printing, the substrates were incubated overnight in a humid chamber and then 
rinsed thrice in a 0.05% Tween solution of PBS followed by a final set of three rinses in 
ultrapure deionizied water. The substrates were then dried under a stream of nitrogen and the 
fluorescence data was acquired soon thereafter. 
4.3.6 Fluorescent sandwich immunoassay 
The protein microarrays were produced using a desktop nanofabrication system, 
NLP2000, based on DPN technology (NanoInk Inc., Skokie, IL, USA).  Prior to printing, the 
tips, DPN Probes type M-ED Side M-2 with 12 A frame cantilevers (NanoInk Inc., Skokie, IL, 
USA), with a pitch between each pen of 66 µm, were plasma cleaned for 40 second at low RF-
value, using a gas mixture of Oxygen/Argon (21% / 79%) at 200 mTorr using a Plasma Cleaner 
(PDC-32G) (Harrick Plasma, Ithaca, NY, USA). Two type of cytokines interleukin 3 (IL-3) and 
tumor necrosis factor (TNF-α) (R&D Systems Inc., Minneapolis, MN) capture antibodies were 
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printed on epoxysilane modified PC slides and Nexterion 1” x 3” Slide E (Schott AG, Maintz, 
Germany) control glass microscope slides. The printing was performed under a controlled 
environment using an environmental chamber (ambient temperature and 30% relative humidity).  
The antibodies (~5.0 mg/mL) where diluted in proprietary printing buffer (NanoInk Inc., Skokie, 
IL, USA); the printing buffer is formulated to keep the protein moisturized and to preserve their 
active and folded states. Four pens out of 12 pens were used to print two cytokine, a positive 
control (goat-anti Rabbit IgG) at 2.0 mg/mL and a negative control (Normal Rabbit IgG labeled 
with Alexa-Fluor-555) at 3.2 mg/mL. Each PC holds 10 subarrays and the glass slides hold 48 
subarrays in a 4 x 12 format; each subarrays contains 4 sets of 4 replicate spots per antibody for a 
total of 16 spots.  Spot diameters were measured to be 15±3.7µm.  The printed substrates were 
incubated in a sealed box with a desiccant for two days at 4o C.  Next, the slides were placed in a 
48 well format slide module assembly (NanoInk Inc., Skokie, IL, USA), were each well could 
hold up to 12 µL.  The arrays were blocked with casein blocking buffer (BioRad, Hercules, CA) 
for 1h.  All incubations were performed at room temperature.  The arrays were then washed three 
times with 0.01% (v/v) tween 20 in PBS (PBST) and then each well was incubated with a 10 µL 
mixture of different antigens concentration in casein buffer for three hours. This was followed by 
three rinses in PBST after which the glass slides was incubated in a bulk dish with 2 ml mixture 
of 1µg/mL biotinylated detection antibodies while the PC substrates waere incubated with only 
10 uL of the biotinylated detection antibody mixture in each well of the slide module assembly 
for 1 hour. The PC substrates and glass slides were then washed three times with PBST, followed 
by the incubation with a 1µg/mL solution of Alexa-Fluor-647 conjugated streptavidin 
(Invitrogen) for 30 minutes. Finally, the devices were washed 5 times with PBST and followed 
by a quick dip in DI water (3 second) to remove the salt, spin dried and then scanned. Antigen 
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standard curves were generated by using a 3-fold dilution scheme for a total of 7 concentrations. 
The starting concentrations for IL-3 and TNF-α were 16.6 ng/mL and 2 ng/mL, respectively. 
4.3.7 Fluorescent miRNA detection 
In this experiment the miR22 probe-target sequence was assayed in a microspot format. 
The capture oligonucleotide sequence (5’-TCA-ACA-TCA-GTC-TGA-TAA-GCT-A-3’, 
purchased from IDT DNA Technologies, Coralville, IA) was modified to have a 6-carbon chain 
amine modification at the 5’ end.  This probe sequence was printed at a concentration of 50uM in 
a printing buffer of autoclaved, Milli-Q water (resistivity of 18.2 MΩ.cm-1) with 80% v/v of 
glycerol (Sigma-aldrich, Saint Louis, MO). A polydimethylsiloxane-based (PDMS; Sylguard 
184, Dow Corning, Midland, MI) 8-well mold was used to create isolated, 4mm diameter wells 
on the printed substrates.  The mold was prepared from a ~1mm thick film of cured PDMS, 
rinsed with IPA and DI water, dried under N2 and firmly placed over the substrate. Through Van-
der-Waal’s forces, the mold remained adhered to the substrate for the course of the experiment. 
In each well, two rows of 8 spots were created for a total of 16 replicate spots per well. 
Printing was performed in ambient temperature and humidity conditions using the e-jet tool. 
Upon printing, the substrates were placed in a petri dish with a moist kimwipe at its base to keep 
the petri dish humid. The dish was sealed with parafilm and incubated overnight. The substrates 
were then rinsed in a wash buffer of DI water with 0.2% v/v of sodium dodecyl sulfate (SDS; 
purchas Sigma Aldrich, Saint Louis, MO), followed by two additional rinses in DI water, and 
then dried under a stream of N2. The target miRNA sequence (5’-UAG-CUU-AUC-AGA-CUG-
AUG-UUG-A-3’; IDT DNA Technologies, Coralville, IA) was labeled with Cyanine-5 at the 5’ 
end. Dilutions of the target sequence was prepared in a buffer of 5X saline sodium citrate buffer 
(SSC, containing 75mM sodium citrate and 750mM sodium chloride) containing 10% v/v of 
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formamide and 0.1% v/v of SDS (all reagents were molecular biology grade and were purchased 
from Sigma Aldrich, Saint Louis, MO). Seven concentrations of the target miRNA sequence 
were assayed over a concentration range of 10nM – 0.6pM; data was obtained from six replicate 
spots per concentration. For the hybridization step, the substrate was placed in a sealable, rubber 
chamber and 10uL of each miRNA dilution was added to a unique well on the substrate. The 
chamber was sealed and left overnight in a water bath at a temperature of 42oC. After the 
incubation period, all wells were aspirated, the PDMS mold was detached, and the substrates 
were rinsed in the following three buffers - (1X SSC containing 0.2% v/v of SDS), (0.2X SSC 
containing 0.2% v/v of SDS), and finally (0.1X SSC). The substrates were dried under a stream 
of N2 and imaged immediately thereafter.  
4.3.8 Confocal laser scanning 
Control glass substrates were scanned with a commercially available confocal laser 
microarray scanner (Tecan LS Reloaded). This scanner was fitted with a 5mW, 632.8 nm laser 
for Cy5 excitation and a Cy5 emission filter (bandpass, 670-715nm). The incident light was TM 
polarized and made incident on the substrates at an angle of 0o. Scans were obtained at a 
resolution of 4um and the photomultiplier tube (PMT) gain was adjusted such that the largest 
fluorescence intensities did not saturate the PMT. 
4.3.9 Angle-tuned, objective-coupled fluorescence line scanner  
The schematic diagram of the objective-coupled line scanning (OCLS) instrument is 
illustrated in the Figure 4.6. The illumination of this system consists of a 70 mw solid-state laser 
(AlGaAs) at 637 nm, coupled to a polarization maintaining fiber, a half wave plate, a cylindrical 
lens, a long pass dichroic mirror, and a 10x objective (Olympus Plan N) of focal length 18 mm. 
The fiber tip is coupled to a fiber collimator giving a highly collimated output beam 3.4 mm in 
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diameter. The output beam is then passed through a half-wave plate, which is used to rotate the 
polarization of the output beam to match with the PC-mode to be excited. The laser beam is then 
focused to a line by the cylindrical lens (f = 100 mm). The focused laser line is directed onto the 
back focal plane of the microscope objective via a dichroic mirror. The output of the objective is 
thus a laser beam focused to a line. The PC is placed on a motorized sample stage (MS2000, 
Applied Scientific Instruments) that is translated perpendicular to the laser line for a fast scan 
(750 lines/second). The fluorescence image is constructed by sequential scanning across the 
sensor in fixed increments. The PC, placed at the focal plane of the infinity-corrected 10× 
objective (f0 = 18mm), interacts with a beam that is collimated in one plane but focused in the 
orthogonal plane. The assembly of the cylindrical lens, half-wave plate and fiber collimator are 
mounted on a two-dimensional motion stage. The stage is manually adjustable in one plane and 
automated in the other. The manual adjustment is utilized to fine-tune the focus of the beam onto 
the back focal plane of the objective lens. In order to achieve angle tuning, the line-focused beam 
is translated on the back focal plane of the objective, by tuning the position of the cylindrical 
lens-wave plate fiber collimator assembly. This fine stepping is achieved by utilizing a motorized 
linear stepping stage (Zaber LSM-25). The result is a change in the incident angle in the ϕ 
direction; here the focal length used would be that of the objective lens. The emitted fluorescence 
signal is collected by the objective and projected onto a CCD camera (Hamamatsu 9100C) by a 
tube lens (f=150 mm). A bandpass fluorescence filter is inserted between the objective and tube 
lens to block the excitation laser beam. 
4.3.10 Image construction  
The image acquisition for the OCLS was fully automated using a C# based user interface. 
The software provides a synchronous integration of the various components of the OCLS. The 
drivers for the Hamamatsu EMCCD, Zaber linear stepping motor and the ASI XYZ-sample stage 
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were written individually and then synchronized using a single program. The final software has 
the ability to capture the angle spectrum of a PC as well as perform fluorescence measurements. 
We utilized the information about the beam shape and size in order to set up an acquisition 
scheme. The user interface requires inputs of start and stop positions for defining a XY scan 
range and an angle scan range. The step size for the XY scan range is 2 µm. This is the effective 
width of an individual pixel on the CCD; the width of the beam is measured to be 6 µm. Thus we 
oversample our images by a factor of 3 in the scan direction. The oversampling is done so that 
only the peak intensity at each pixel is used to generate the image. If we were to utilize a step 
size equal to the focus beam width, we would encounter a variability of ±25% in the scan 
direction as opposed to a variability ±6%. The tradeoff here is a 3× slower scan speed due to the 
shorter step size. The motivation for the new image-processing algorithm came as we recognized 
that by only selecting the peak intensity value, we effectively discard valuable data from the 
lower intensity pixels adjacent to the peak. The image processing algorithm works on the 
assumption that, as we step through a 6 µm region, we are illuminating the region with a 
different intensity beam. If we aggregate the fluorescence emitted for all three frames, our final 
intensity value for that pixel should be over 2× without increasing the laser power or integration 
time. Thus if we do need to oversample in steps to achieve the lower variability in the scan 
direction, we can utilize a clever algorithm to artificially enhance the integration time as well. 
This algorithm is depicted in the Figure 4.7. Position 2 indicates the peak value that we would 
normally utilize and the processed peak indicates the aggregated intensity value we obtain. 
Owing to this processing algorithm we further noticed that we lowered the variability in the scan 
direction by 3×, due to the flat-top effect for a Gaussian profile. Theoretically, a Gaussian 
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convolved with a Gaussian gives a flattop beam. This algorithm results in an optical convolution 
that allows reduction of variability and hence noise. 
4.3.11 Image analysis and quantification  
Spot segmentation and intensity calculations of the constructed fluorescence images were 
performed using either ImageJ or Genepix Pro 6.1 (Molecular Devices). Net spot intensity was 
calculated as the local background subtracted spot intensity where the local background is an 
annular region around a given spot. Spot SNR was calculated as the local background subtracted 
spot intensity divided by the standard deviation of the local background. 
4.4 Results and discussion 
4.4.1 Device surface and optical characteristics 
Silicon-based PCs provide substantial advantages compared to previously reported PCEF 
surfaces prepared on plastic or quartz substrates. First, these devices can be fabricated on a wafer 
scale with semiconductor process technology and is thus amenable to inexpensive, high volume 
manufacturing. Second, the SiO2 and TiO2 materials of the PC have negligibly low levels of 
autofluorescence, thus enabling weak fluorescent signals generated by low concentration 
analytes to be more easily observed.  As demonstrated in this work, Si PCs provide narrow 
bandwidth optical resonances, which have been shown to generate the greatest fluorescence 
enhancement factors when the excitation illumination matches the resonance wavelength and 
coupling angle. 
The broadband optical properties of the silicon PC (Si-PC) as measured from a finished 
device are presented in Figure 4.8(a). Here the reflected spectra for a silicon PC both at normal 
and at 3.5 degrees (resonance peak at the Cyanine-5 excitation wavelength of 637 nm) is 
presented; the peak has a full width at half maximum (FWHM) of 2nm.  The broad features 
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observed in the reflection spectrum are a result of the thin film interference of the SiO2 and TiO2 
thin films, while the high efficiency, narrow reflection peak results from the presence of the PC, 
and indicates the wavelength at which PC resonance is established.  The optical response of a Si-
PC over a range of illumination angles and a fixed illumination wavelength (λ=637 nm, in this 
case) was also obtained to characterize the device angular profile and accurately identify the 
device resonant angle (see Figure 4.8(b)) for a fixed wavelength. For the sake of completeness, 
the broadband optical properties of the initial prototype devices fabricated using nano-imprint 
lithography are presented in Figure 4.9. 
 
Finite Difference Time Domain (FDTD) computer simulations were used to aid in the 
design of the structure shown in Figure 4.1, and to thus predict the resonant spectrum expected 
from the structure.  FDTD also enables visualization of the electric field distribution on the PC 
surface at the resonant coupling condition.  As shown in Figure 4.10, excellent agreement was 
observed between the simulation and measured broadband optical responses in key parameters 
such as the spectral location of the peak, the peak width, and its reflection efficiency. The model 
can be used to estimate the potentially available excitation enhancement provided by a PC 
structure where the incident excitation light is collimated and matched to the PC resonant 
coupling condition. We report a maximum electric field enhancement of 1767 times the incident 
electric field and an average electric field enhancement of 401 times and 135 times the incident 
electric field for 10nm and 100nm tall regions extending above the TiO2 layer into the device 
superstrate (air, in this case). Our design goal is to provide a narrow high reflection efficiency 
peak, as the potential enhancement is inversely proportional to the bandwidth of the resonance, 
as shown in previous work 28. 
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4.4.2 Objective-Coupled Line Scanning (OCLS) Detection Instrument 
A critical aspect of the Si-PC detection platform is the design of the detection instrument 
used for fluorescence excitation, and imaging of fluorescence emission.  The goal of the 
detection instrument is to illuminate the PC at the exact wavelength/angle combination that 
satisfies the resonant condition.  Because light focused to a point contains a wide range of 
incident angles, only a small fraction of the incident light will be resonant with the PC, and thus 
the enhancement effect provided by point-focused light is not capable of achieving the maximum 
available enhancement effect 29.  One approach to overcome this problem is to illuminate a broad 
area of the PC with collimated light, which unfortunately results in substantially reduced 
excitation intensity compared to a focused beam 35.  Here, we take advantage of the unique 
optical properties of the linear PC grating structure, for which the resonant coupling condition 
only need be satisfied for incident angles oriented perpendicular to the grating lines.  As 
described previously 36 a cylindrical lens may be used to provide light that is focused in the plane 
parallel to the grating, but completely collimated in the plane perpendicular to the grating, thus 
simultaneously achieving nearly 100% resonant coupling to the PC, and a high intensity focused 
line of illumination, with a line width of 6µm.  
A schematic diagram of the detection instrument is shown in Figure 4.6. It is comprised 
of a solid-state laser (637 nm line, 70mW) that is coupled to a polarization maintaining fiber 
which has a fiber collimator at its tip, a half-wave plate to rotate the incident polarization to 
match the PC-mode of interest, a cylindrical lens, a long pass dichroic mirror and finally a 10x 
objective lens. By passing the laser beam through this lens system, the final illumination beam is 
shaped into an 8µm x 1mm line that is focused along the direction of the PC grating while 
remaining collimated in the direction perpendicular to the grating. The PC is placed on a 
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motorized sample stage that is translated perpendicular to the laser line to scan the area of 
interest. The cylindrical lens, half-wave plate, and fiber collimator are placed on a motorized 
stage. By tuning the position of this assembly, the incident angle is modulated in the direction 
perpendicular to the PC grating.  Fluorophore emissions are collected by the objective, passed 
through a bandpass fluorescence filter and finally through a tube lens that is fitted with a CCD 
camera. A fluorescent image of the PC surface is obtained by adjustments of the incident angle 
of the illumination line upon a region of the PC adjacent to the microarray, and then translating 
the PC holding stage in increments of 2 µm past the assay region, gathering a fluorescent 
intensity image of the line for each motion increment.  Using custom software, the assembly of 
the fluorescent image of each line into a two-dimensional image of fluorescent intensity is 
performed.  For the arrays used in this work, a single scan is performed in  
60 seconds.   
4.4.3 Fluorescence enhancement characterization 
Initial bulk fluorescence enhancement measurements on the Si-PC as compared to an 
unpatterned glass control substrate were performed by spin coating an LD-800 (dye) doped layer 
of SU-8 (photoresist) onto cleaned devices. Fluorescence data on all substrates was acquired 
using the OCLS instrument at a fixed laser power of 3mW. CCD exposure time was adjusted to 
maximize fluorescence output on each substrate and gathered measurements were later 
normalized based on the exposure setting to allow for comparisons between substrates. 
Fluorescence signal enhancement is defined as the ratio of the system dark noise subtracted 
maximal fluorescence intensity of the PC to a control glass substrate. When scanned on 
resonance, a 96.7x factor in fluorescence enhancement was observed on the Si PC as compared 
to its off resonance condition, representing the gain supplied by the enhanced excitation effect.  
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Next, we characterized the device fluorescence enhancement performance in the context 
of a simple microarray assay where microspots of streptavidin labeled with Cy5 were deposited 
on a silane functionalized PC. Such an experiment provides a measure of net fluorescence signal 
intensity enhancement as well as another important parameter of signal-to-noise ratio (SNR) 
enhancement. Enhancements in the SNR are especially meaningful as they more readily translate 
to lowering the limits of detection for a biological specimen because such gains indicate an 
enhancement in the fluorescence intensity that is greater than any associated increases in the 
background fluorescence intensity. An average fluorescence signal enhancement of 113.5x and 
an average SNR enhancement of 10.3x was observed when the Si PC resonance was excited.   
By utilizing the high resolution printing capability of the e-jet platform 33-34 and the 
capability to acquire fluorescence data at precisely tuned angles of incidence with the OCLS 
system, the printing of an optical illusion known as Rubin’s vase (Figure 4.11a) was attempted 
on a Si-PC. This set of reversing figures consists of a face and a vase in the same image. We 
attempted to print the two complementary figures using two different inks – Cy5-labeled 
streptavidin (purchased from GE Healthcare; printing concentration of 100 µg/mL, diluted in 
PBS with glycerol added at 80% v/v) and a Cy5-labeled oligonucleotide (purchased from 
Integrated DNA Technologies; sequence 5’-AT TTC CGC TGG TCG TCT GCA-3’, six-carbon 
amine modification on the 5’ end and Cy5 label on 3’ end; printing concentration of 1nM, 
diluted in sterile MilliQ water with glycerol added at 80% v/v). The e-jet deposited spots had a 
resulting diameter of ~40-50 µm.  Drying of the droplets after deposition resulted in surface 
adsorption of dye-labeled biomolecules around the perimeters of adjacent droplets, resulting in 
doughnut-shaped fluorescent spot morphology.  Printing of spots into a dense array, thus results 
in a “chain link” appearance to the resulting image, where the regions between applied droplets 
86 
 
are bright, and fluorophore is not observed in the droplet centroid. Adsorption of surface layers 
on the PC surface will shift the resonant coupling angle to greater values, proportional to the 
density of the adsorbed layer 35, 37. Because the protein-printed region has a greater surface 
density than the oligonucleotide-printed region, its resonant coupling angle is ~ 0.1 degrees 
higher. By tuning to each resonance angle, one for the oligonucleotide printed section and the 
other for the protein printed section, the face or vase components of this image can be observed 
without exciting the complementary component. (Figure 4.11 b, c).  This experiment 
demonstrates the importance of illuminating the PC so as to excite the resonance, as regions of 
the PC that are illuminated at an angle that does not match the resonance will experience 
substantially lower surface-bound excitation intensity, and will appear dark next to regions that 
are illuminated on-resonance.  This experiment also serves to demonstrate the ability of the 
OCLS system to obtain uniform, high resolution images of fluorescent intensity. 
4.4.4 Fluorescent immunoassay and miRNA microarray 
The performance of the Si-PC coupled with the OCLS detection system was next studied 
in the context of a microspot-based fluorescent sandwich immunoassay. Si-PCs paired with glass 
control slides were partitioned into 8-sectors; in each sector four replicate microspots each of 
capture antibodies for IL-3 and TNF-α were printed using a dip-pen nanolithography system 38-39 
.  A mix of IL-3 and TNF-α was assayed in these sectors over a range of 7 concentrations in a 3-
fold dilution series with a starting concentration of 16.6 ng/mL for IL-3 and 2ng/mL for TNF-α. 
Assay details are described in Methods. Fluorescence images for the Si PC were obtained with 
the OCLS and that for the glass control slide were obtained using a commercially available 
confocal microarray scanner (Tecan-LS, laser wavelength of 632.8nm). Figure 4.12 presents 
87 
 
representative fluorescence images of microspots on the PC and glass surfaces at two sets of 
assayed concentrations.  
 
The dose-dependent response of each antigen assayed is presented in Figure 4.13. The 
lowest concentrations of TNF-α and IL-3 detected on the glass surface were 24.69 pg/mL and 
205.76 pg/mL, respectively. In comparison, all seven assayed concentrations were detectable on 
the PC with the lowest concentrations being 2.74 pg/mL and 22.86 pg/mL for TNF-α and IL-3 
with replicate averaged SNRs of 24.6 and 45.4, respectively. In Figures 6c-d, the red line 
represents the fluorescent intensity value measured in the regions directly adjacent to the 
microarray spots, thus establishing the local fluorescent background level.  Negative controls 
performed by exposure of capture antibodies to a buffer-only sample resulted in no observable 
fluorescence signal above this background. 
Finally, we characterized the performance of a miRNA microspot assay on the Si PC 
where we chose to assay miR-21, a miRNA sequence implicated in the progression of breast 
cancer 40. The miR-21 target miRNA sequence was assayed on the PC at the following seven 
concentrations - 10nM, 2.5nM, 156pM, 39pM, 9.8pM, 2.4pM, and 0.6pM. All seven 
concentrations yielded detectable signals with the lowest concentration of 0.6pM having a 
replicate averaged spot SNR of 3.8. The dose response of the assayed set of concentrations is 
presented in Figure 4.14. 
A noted difference in the broadband optical response of the silicon PC over previous 
generation of the PCs is the presence of the wider, side lobes beside the high-Q PC resonant 
peak. These are the result of constructive interference between the silicon and silicon oxide 
layers in this structure. Previous reports have utilized this interference phenomenon to enhance 
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fluorescence output by tuning the silicon oxide thickness such that an interference peak is 
aligned with the fluorphore excitation peak 41. Furthermore, since these interference peaks have a 
width of ~ 180nm and can be made to overlap the excitation peaks of multiple fluorophores, the 
simultaneous fluorescence enhancements of Cy3 and Cy5 fluorphores by a single structure has 
been reported. Fluorescence enhancements of factors of 5-10x have been reported. By tuning 
such an interference peak to overlap the PC resonant peak, a multiplicative increase in the overall 
fluorescence is anticipated. The initial design of the silicon PC was aimed at creating this overlap 
between the two peaks for maximal enhancement and was successfully achieved for normal 
incidence excitation (0 degrees) of the PC resonance. However, control over the overlap of these 
peaks for off normal excitation has not been pursued here mainly due to the scope of this study. 
Since in this study, the PC structure with a fixed silicon and oxide thickness has been used for a 
variety of different assays, the incident angle needed to excite an off-normal PC resonance (also 
referred to as the PC resonant angle) has been different for each assay since this resonant angle is 
a function of the effective refractive index of the biolayer present atop the sensor surface. Due to 
differences in the rates at which the split PC peaks and the interference peaks are spectrally 
shifted for off-normal illumination, we have not pursued the precise alignment of these peaks for 
further fluorescence enhancement. However, for a fixed PC resonant angle, it is feasible to 
design a device where an interference peak is aligned to overlap the PC resonance. This will be 
pursued for standardized microarray experiments in the future and a further increase in the 
fluorescence enhancement is anticipated.  
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4.5 Conclusions 
  In this chapter we have presented a miniaturized and inexpensive platform for the 
detection of soluble biomarkers. For the first time, PCs have been fabricated on a silicon 
substrate, using materials (SiO2 and TiO2) with very low levels of autofluorescence. By choosing 
such a device design, the detection of weak fluorescent signals generated at lower analyte 
concentrations can be more easily observed. These devices have been successfully designed and 
fabricated inexpensively at a semiconductor foundry. An objective-coupled line scanning 
detection instrument designed to efficiently couple incident light to PC resonant modes also 
enabling the detection of otherwise weak fluorescent signals is presented. Finally, the adoption 
of dip-pen nanolithography and e-jet printing technologies to create microspots with a diameter 
<50 µm minimizes the usage of capture molecules and the size of the array. The capabilities of 
this system have been demonstrated in the context of two fluorescent assays. Most importantly, a 
fluorescent immunoassay for two breast cancer biomarkers (TNF-α and IL-3) and one miRNA 
biomarker, miR-21 was performed using only 10 µl sample volumes, consistent with detection 
from a droplet of fluid. The protein and miRNA biomarkers were detected at concentrations as 
low as 0.1pM and 0.6pM, respectively. It is anticipated that such a high sensitivity platform with 
a low cost-per-test will have applications in multiplexed soluble protein biomarkers analyses as a 
diagnostic tool. 
 4.6 Figures  
 
Figure 4.1 Schematic of the Silicon PC device design.
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 Figure 4.2 SEM images of prototype Si PCs fabricated 
views of a device after the lithography step and before any TiO
and (d). 
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in-house using nano-imprint lithography. (a) Top view and (b) cross sectional 
2 coating. Images of a completed device with TiO
 
2 are presented in (c) 
  
 
Figure 4.3 Images of a Si PC fabricated using a DUV process by a semiconductor foundry. (a
in SiO2 layer before TiO2 coating. The grating line width and grating depth we
Top view of PC after TiO2 coating. The grating per
in2. piece. 
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) Cross-sectional view of grating pattern 
re measured to be 131nm and 37.7nm, respectively. (b
iod was measured to be 366nm. (c) Picture of finished device diced into a 1 x 0.5 
 
) 
 Figure 4.4 Additional images of Si PCs fabricated by a semiconductor foundry. 
PC grating in SiO2 and before the TiO2 coating. Measured grating depth of 37.7nm and grating line width of 131nm. (b) Atomic force 
micrograph of device after TiO2 coating with a measured period of 352 ± 7nm and grating depth of 37 ± 1.8nm. (c) PC grating 
patterned on an 8” wafer. Individual devices are diced to 1” x 0.5” pieces. 
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(a) Cross-sectional SEM image of two periods of the 
 
 
 Figure 4.5 (a) Schematic of the optical setup used to characterize the reflection efficiency of the Si PCs. Reflection and transmission 
efficiency measurements of a plastic-based, transparent PC (b) at normal incidence and (c) off
agreement was observed between the reflection and transmission profiles with 
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-normal. In using this setup, good 
only slightly lower efficiencies in the reflection spectra.
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Figure 4.6 Schematic of the objective-coupled, line scanning instrument used to acquire fluorescence data at the precise PC resonant 
angle. Equipped with a solid-state laser diode, this instrument illuminates the PC with a beam of light that is focused in one plane for 
higher illumination density but collimated in the other plane for optimally coupling the incident light to the PC. 
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Figure 4.7 A graph depicting the signal distribution in the focused direction of the illuminating 
line as it steps through three adjacent positions on the sample. The positions are 2 µm apart. The 
black curve indicates the summation of all three curves at each pixel that is 2um wide. 
 Figure 4.8 (a) Reflection spectra of a 
light source and captured at normal incidence (black) and at an incidence angle of 3.5 degrees 
(red). At an incidence angle of 3.5 degrees
λ=637nm. (b) Reflection spectra of a Si PC obtained when illuminated with a collimated solid 
state laser (at λ =637nm) over a range of illumination angles. All data is normalized to the 
reflection from a gold mirror. 
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foundry fabricated Si PC illuminated with a broadband 
, the resonant peak is located at a wavelength of 
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Figure 4.9 Reflection spectra of a prototype Si PC fabricated in-house using a nano imprint 
lithography process. Illuminated at normal incidence with a broadband light source, the device 
reflection was obtained for TM polarized light (black), TE polarized light (red), and for TM 
polarized light on a region off the PC grating (blue) where a peak is observed due to constructive 
interference between the stack of Si, SiO2, and TiO2 films.
  
Figure 4.10 Reflection efficiency as a function of wavelength for the simulated Si
incidence, the device resonance is located at 633nm. (b) Electric field intensity cross section plotted for one period of the
maximum field intensity is 1767 times the incident field intensity. When averaged over a 10nm and 100nm tall region above the top 
TiO2 layer, the electric field intensity is 401 times and 135 times the incident field intensity, respectively.
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-based photonic crystal. When illuminated at normal 
 
 
 device. The 
 Figure 4.11 (a) The optical illusion, Rubin’s vase, shown here as a gray
vase. (b-c) Fluorescent images of the two reversing figures obtained by tuning to two distinct PC resonances. The two figures were 
printed with a Cy5 labeled oligonucleotide and a Cy5 labeled protein, respectively and each figure produced a separate shift i
resonance. Printing was performed using a high
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-scale image consists of two reversing figures of a face and a 
-resolution e-jet printing platform. 
 
n the PC 
 Figure 4.12 Representative fluorescence images of two subarrays on the glass slide (a
microarray scanner. Two assayed concentrations of (a) 222.2pg/mL for TNF
α and 205.76 pg/mL for IL-3 are presented here. Fluorescent images of two subarrays on the Si PC (c
the following concentrations (a) 24.69 pg/mL for TNF
for IL-3.   
101 
-b) acquired using a commercial confocal 
-α and 1.85ng/mL for IL-3 and (b) 24.69 pg/mL for TNF
-d) acquired using the OCLS at 
-α and 205.76 pg/mL for IL-3 and (b) 2.74 pg/mL for TNF
 
-
-α and 22.86 pg/mL 
  
Figure 4.13 Dose response curves obtained on the glass slide for (a) IL
five highest concentrations out of a total of seven assayed concentrations were detectable on the 
glass slide. All seven assayed concentrations of (c) IL
PC. Fluorescent spot intensities on the PC for the four lowest assayed concentrations, as 
highlighted in the blue rectangle and magnified, are well above the local background value (red 
line). Data represents mean ± S.D. values of four r
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-3 and (b) TNF
-3 and (d) TNF-α were detectable on the 
eplicate spots. 
 
-α. The 
 Figure 4.14 Dose response curve depicting fluorescent spot intensities of mir
PC over a concentration range of 1nM 
detectable over the background fluorescence signal with 
highlighted in the blue rectangle and magnified.  The local background is indicated as the red 
line. Representative fluorescence images of microspots at assayed miR
2.5nM and 39pM are presented al
sixteen replicate spots. 
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-21 assayed on the 
– 0.6pM. All seven assayed concentrations were 
the four lowest assayed concentrations 
-21 concentrations of 
ongside each graph. Data represents mean ± S.D. values of 
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CHAPTER 5 CONCLUDING REMARKS 
 
5.1 The future research direction of photonic crystal enhanced fluorescence                                                    
The addition of blood-based molecular biomarkers to current approaches holds great 
promise to improve cancer risk assessment, to detect cancer at an early stage, reduce unnecessary 
invasive diagnostic procedures, and to assess treatment response early and non-invasively. 
Reports have been made on optical and electrochemical approaches that are capable of detecting 
blood-based protein biomarkers at levels of a few pg/mL - which is at or below the normal levels 
of several cancer biomarker proteins. PCEF is one such approach that utilizes nanotechnology 
and we have demonstrated competitive detection sensitivities for clinically important levels of 
biomarkers. Due to the diverse nature of both the disease and its patient population, cancer 
detection and diagnostics using protein biomarkers will require accurate detection of a panel of 
an estimated four to ten biomarkers for each cancer. Much less progress has been made on this 
front with many of the existing approaches. We have successfully demonstrated the application 
of PCEF to a panel of 21 breast cancer biomarker panel with recorded improvements in detection 
sensitivity of 5-90% and detection limits of 2.1-41 pg/mL across the different biomarkers 
assayed 1-2. It is now important to proceed to validate the PCEF approach by extensive testing on 
patient samples such as serum or saliva to establish analytical reliability as well as clinical 
sensitivity and selectivity. 
 Currently no platforms for the multiplexed cancer biomarker detection are in widespread 
use in point-of-care (POC) settings. However commercial bead based methods that utilize 
electrochemiluminescence and fluorescence have been successfully used for laboratory-based 
sample testing despite the high cost for detection instrumentation (typically upwards of $20,000). 
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A viable POC platform will need to be simple, low cost, and require a technical method that is 
not very demanding or one that needs specialized training for users. While electrochemical 
approaches are inherently inexpensive, the same cannot be said about optical methods. A 
significant portion of the cost of an optical-based system comes from the detection 
instrumentation. With this in mind, the OCLS system has been designed to be a low-cost system. 
In its current incarnation and with the replacement of the EM-CCD with a photomultiplier tube 
detector, the cost of the OLCS instrument is <$10,000. Furthermore, while the  current compact  
size  of  the  fluorescence  instrument  is  impressive,  this  can  be  further  scaled down  to  
create  a  truly  miniaturized  point-of-care  detection  system.  
Finally, the marriage of sensitive, reliable, and simple detection protocols with 
microfluidics for sample handling on-chip is a necessary future step for the PCEF platform to 
reach true POC status. While the advantage of a microarray-format based detection platform 
where fluorescence measurements are measured in dry condition can be retained, if real-time, 
flow-based analyte detection is desired, special considerations will need to be given to the device 
design and instrumentation for in-fluid, fluorescence measurements. 
Significant funds and efforts have been committed to the future of cancer diagnostics 
with the hope of solving several existing formidable analytical challenges; if successful, the 
payoff and utility of such a detection platform will be great. 
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